Abstract
Background: Antimicrobial resistance represents a serious threat to human health across the globe. The cost of bringing a new antibiotic from discovery to market is high and return on investment is low. Furthermore, the development of new antibiotics has slowed dramatically since the 1950s’ golden age of discovery. Plants produce a variety of bioactive secondary metabolites that could be used to fuel the future discovery pipeline. While many studies have focused on specific aspects of plants and plant natural products with antibacterial properties, a comprehensive review of the antibacterial potential of plants has never before been attempted.
Objectives: This systematic review aims to evaluate reports on plants with significant antibacterial activities.
Methods: Following the PRISMA model, we searched three electronic databases: Web of Science, PubMed and SciFinder by using specific keywords: “plant,” “antibacterial,” “inhibitory concentration.”
Results: We identified a total of 6,083 articles published between 1946 and 2019 and then reviewed 66% of these (4,024) focusing on articles published between 2012 and 2019. A rigorous selection process was implemented using clear inclusion and exclusion criteria, yielding data on 958 plant species derived from 483 scientific articles. Antibacterial activity is found in 51 of 79 vascular plant orders throughout the phylogenetic tree. Most are reported within eudicots, with the bulk of species being asterids. Antibacterial activity is not prominent in monocotyledons. Phylogenetic distribution strongly supports the concept of chemical evolution across plant clades, especially in more derived eudicot families. The Lamiaceae, Fabaceae and Asteraceae were the most represented plant families, while Cinnamomum verum, Rosmarinus vulgaris and Thymus vulgaris were the most studied species. South Africa was the most represented site of plant collection. Crude extraction in methanol was the most represented type of extraction and leaves were the main plant tissue investigated. Finally, Staphylococcus aureus was the most targeted pathogenic bacteria in these studies. We closely examine 70 prominent medicinal plant species from the 15 families most studied in the literature.
Conclusion: This review depicts the current state of knowledge regarding antibacterials from plants and provides powerful recommendations for future research directions.
Introduction
Antimicrobial resistance (AMR) threatens the ability to successfully treat infectious diseases across the globe (McEwen and Collignon, 2018). While many factors such as the unnecessary prescription of antimicrobials and their use in agriculture contribute to the spread of AMR, a combination of scientific and economic challenges in antimicrobial development has caused the pipeline of new drugs to decline (WHO, 2019a; WHO, 2019b). Annual deaths worldwide due to AMR continue to climb to around 750,000 and are projected to reach as high as 10 million by the year 2050 (O’Neill, 2016). Whereas AMR refers to resistance in bacteria, fungi, viruses and protozoans, antibiotic resistance refers to resistance specifically in bacteria, which is the focus of this review.
To counteract the lack of new antibacterials and the rise of antibiotic resistance, plants could represent a potential solution. Indeed, plants are equipped with an array of effective defense mechanisms, such as the production of secondary metabolites, to combat pests and pathogens before they are able to cause serious damage. Plants and other organisms have co-evolved for more than 350 million years (; ) and have developed strategies to overcome each other’s defense systems. Plant secondary metabolites play a major role in how plants adapt to their environment; they also act as their surveillance system. They are byproducts of non-essential metabolic pathways and are responsible for the specific odors, tastes and colors of plant tissues. Plant secondary metabolites can also help the plant to cope with abiotic stresses (e.g., UV radiation) and to communicate with other organisms (e.g., herbivores, pathogens, neighboring plants, pollinators and fruit dispersers), so they are also important for growth and development (; Zaynab et al., 2018; Wink, 2020). These compounds usually belong to one of three large chemical classes known for biological activity: terpenoids, phenolics and alkaloids. In particular, terpenoids represent one of most diverse secondary metabolite groups and include more than 50,000 known compounds (; ).
Plants are also highly biodiverse. The most recent estimates place the total number of plant species at approximately 374,000 (). This includes described and accepted vascular plant species, of which 295,383 are angiosperms (monocots: 74,273, eudicots: 210,008), 1,079 are gymnosperms, 10,560 are ferns, 1,290 are lycopods, and the rest are bryophytes and algae (). This represents ten times as many species as all terrestrial vertebrates combined. With regards to geographic location, the most species-rich areas of the world with an estimated 44% of all plant diversity are confined to 25 hotspots with 1.4% of the total land area on the planet (Myers et al., 2000). These areas remain richly biodiverse with approximately 290,000 unstudied plant species with countless secondary metabolites (RBG and Willis, 2017).
Throughout history, humans have relied on plants as a source of medicine. Evidence for the historical role of plants in treating human disease is documented by the long history of medical texts from civilizations across the globe. The oldest written record of medicinal plants, dated 2600 BCE, was written in cuneiform on clay tablets in Mesopotamia and recorded the use of oils from the Mediterranean cypress tree (Cupressus sempervirens L., Cupressaceae) and opium poppy (Papaver somniferum L., Papaveraceae) (). The next oldest written record was found in Egypt, the 3,500-year-old Ebers Papyrus (1553-1550 BCE) (). The Ebers papyrus is a well-preserved scroll detailing a variety of plants traditionally used for a wide range of diseases in ancient Egypt ().
Today, in many parts of the developing world, between 70 and 95% of people continue to rely on plants as a primary form of medicine, and many countries have integrated traditional plant-based medicines through regulations into mainstream healthcare systems (RBG and Willis, 2017). Plant-based medicines also continue to make up a key component of intercultural healthcare, encompassing biomedical and traditional medical approaches, in minority and underserved communities (Vandebroek, 2013). According to the Medicinal Plant Names Services (MPNS), 28,187 species (∼7.5% of all plant species on Earth) are recorded as being used medicinally (MNPS, 2020), but only 4,478 are cited in medicinal regulatory publications (RBG and Willis, 2017).
Complex mixtures of compounds found in nature represent an interesting source of bioactive compounds, as they can act in synergy. Mechanisms by which plant compounds can synergize in this way include targeting multiple receptors, facilitating transport to a target, protection from degradation and modification of resistance (). The widespread presence of synergistic interactions in plant extracts is evidenced by the frequent loss of activity upon fractionation (; ). There is a growing recognition in the field that the pursuit of single active compounds through bioassay-guided fractionation is not sufficient to capture the potential of plant compounds as antibacterials—synergy and other interactions must be studied (). In addition to the study of interactions within plant extracts, many recent innovations involve finding plant compounds that synergize with existing antibiotics, particularly as resistance-modifying agents for use against drug-resistant bacteria (; ; ).
In cases where synergy is found in plant extracts, options such as the FDA Botanical Drug Guidance exist for the development of whole extracts or refined fractions as drugs (). Two botanical drugs have been approved by the FDA: Veregen (sinecatechins), a green tea extract (Camellia sinensis (L.) Kuntze, Theaceae) for the treatment of genital and perianal warts, and Fulyzaq or Mytesi (crofelemer) from the dragon’s blood tree (Croton lechleri Müll.Arg., Euphorbiaceae), used to treat diarrhea associated with HIV anti-retroviral therapy (Wu et al., 2020).
Thousands of laboratory studies have been conducted on the antibacterial potential of plants since the 1940s. However, a comprehensive review of this body of work, with rigorous inclusion and exclusion criteria based on the scientific rigor of studies, has never before been attempted. While it is well known that certain plants exhibit antibacterial properties in laboratory studies, little is still understood about which specific botanical taxa have exhibited the most promising activity against pathogenic bacteria to date. Here, we present a comprehensive analysis of the literature on plants used as antibacterials by focusing on their reported growth inhibitory activity.
Methods
Terminology
Botanical Terminology
All reported plant names were cross-checked for accuracy in accordance with The Plant List (http://www.theplantlist.org/), the International Plant Names Index (http://www.ipni.org/index.html), the World Checklist of Selected Plant Families (https://wcsp.science.kew.org/) and Tropicos (https://www.tropicos.org/home). Plant family assignments follow the Angiosperm Phylogeny Group IV guidance (). Any botanical synonyms or citations with unaccepted author epithets were updated to the current corrected nomenclature and are reported as such both in the supplementary material data tables and manuscript text.
Antibiotic Terminology
In this review, we define antimicrobials as agents that inhibit the growth of microbes (bacteria, fungi, viruses, and protozoans). We define antibiotics as agents that inhibit the growth of bacteria specifically, and we consider antibiotic effects to be synonymous with antibacterial effects. The minimum inhibitory concentration (MIC) is defined as the lowest concentration of an antimicrobial agent that inhibits visible growth of a microorganism in vitro (). This value is commonly used as an indicator of antimicrobial potency. In combination with pharmacokinetic/pharmacodynamic parameters, the MIC is also used to predict the antimicrobial efficacy in vivo (). We also define the MIC as the lowest concentration of an antimicrobial agent that inhibits 90% of bacterial growth as detected by optical density measurement of liquid culture medium. The IC50 refers to the concentration of agent inhibiting 50% of the bacterial growth as measured and reported by optical density. All reported bacterial names were cross-checked for accuracy and updated in accordance with the List of Prokaryotic names with Standing in Nomenclature (LPSN) at https://www.bacterio.net/.
Literature Search
We followed the Prisma guidelines to perform our literature search (Moher et al., 2009). We systematically assessed the scientific literature collected from the Web of Science, PubMed and SciFinder scientific databases, considering all the articles published between 1946 and 2019 (September 3, 2019). The keywords “plant,” “inhibitory concentration” and “antibacterial” were used.
Inclusion and Exclusion Criteria
Article titles and abstracts were manually screened to exclude studies not related to the topic. Only vascular plants (i.e., angiosperms, gymnosperms, ferns and lycopods) were included in the analysis. Relevant articles were examined to determine fit to the eligibility criteria of this review.
The specific inclusion criteria include the following:
(1) Validated source of material: plant materials were identified to the taxonomic level of genus and species with plant voucher specimens collected and deposited in a herbarium, university or research institute.
(2) Appropriate methodology: standard methods for antibacterial assays were employed using broth microtiter dilution methodologies following established criteria (CLSI, EUCAST, NCCLS) (; ; ; Sarker et al., 2007), bacterial inoculum (1 × 105 CFU/mL ≤ inoculum ≤ 1 × 107 CFU/mL equivalent to 0.5 McFarland (1.5 × 108) with dilution from 1:15 to 1:300) and time of incubation (≤24 h, except Mycobacterium sp. and Helicobacter pylori).
(3) Appropriate MIC or IC50 values (; ; ): for plant extracts, only MICs ≤500 μg/mL or IC50 ≤ 100 μg/mL were included. Reported IC90 values were considered the MIC.
(4) Access to the full-text article in the English language. Articles published only in non-English languages were excluded.
Data Extraction
Data are tabulated in Supplementary Material S1 and were also deposited in the Shared Platform for Antibiotic Research and Knowledge (SPARK) with Pew Charitable Trusts, accessible at https://app.collaborativedrug.com/vaults/4724/protocols. Registration for a SPARK account is free and available at http://www.pewtrusts.org/spark-antibiotic-discovery.
Whenever provided, information on the resistance background of strains tested or the ethnopharmacological uses of the plant species is included in Supplementary Material S1. Plant tissue extracted and extraction methodology was also noted when provided in the original publication. The units of MIC and IC50 were converted to either µg/mL or µL/mL for plant extracts and essential oils (EOs), respectively. Categories of ethnomedical use were assigned to the data set by organ system, divided across 13 categories: Cardiovascular, Dermatological, Endocrinological, Gastrointestinal, General Health, Genitourinary, Gynecology and Andrology, Musculoskeletal, Neurological and Mental Health, Ophthalmological, Oral Health, Otolaryngological and Respiratory and Not Specified. The International Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD-10) (WHO, 2016) was considered, but ultimately not used due to lack of specificity of disease origins in the reviewed literature. Information on the use of plant extracts in clinical trials was obtained from clinicaltrials.gov (NLM, 2020). Based on the same literature search, we examined the antibacterial activities of plant-derived compounds in another review (Porras et al., 2020).
Data Analysis
Data obtained from the literature search was maintained and organized in Microsoft Excel, then analyzed and visualized using Graphpad Prism 8; analysis of MIC values was done by one-way ANOVA with Tukey’s multiple comparisons test. Statistical significance was defined as p value <0.05.
To generate the euphyllophyte tree, text file R20160,415_euphyllophyte.new () in Newick format was used as the backbone. Plant families were graphically displayed using iTOL (). The resulting euphyllophyte family tree from R20160415.new has high resolution, containing only branches with confidence levels (Bootstrap values or posterior probabilities from Bayesian analysis) larger than 80%. It includes 13 gymnosperm, 37 monilophytes families and all the 64 orders and 416 Angiosperm families recognized by APG IV (; ). Percentages of studied genera calculated using the total number of genera and species for each family are reported according to the Angiosperm working group version 14 (Stevens, 2001) (Supplementary Material S2.1).
Results
Literature Assessment
The process of identification and screening of articles for this review is represented in Figure 1. The literature search yielded 9,527 articles from which 3,444 duplicates were excluded. Of these 4,024 publications, only 483, or 12%, passed the rigorous criteria required for inclusion in this review. This highlights the need for broader implementation of robust standards for research in this space—from authentication of botanical starting materials to application of standardized laboratory approaches in the evaluation of plant extracts. Nevertheless, as shown in Figure 2, the number of publications related to plants with antibacterial activity has increased significantly in the last decade. In accordance with these trends and the broad application of standardized methods for the antibacterial assessment of extracts, the present review focuses on studies published from January 1, 2012 to September 3, 2019, representing 4,024 articles, or 66% of all papers published under these search criteria since 1946.
FIGURE 1
FIGURE 2
In the following sections, we provide an overview of the 958 plant species (representing 4,943 MIC values) with reported antibacterial activity recorded in our literature search (Supplementary Material S1). We discuss their diversity from a taxonomic and phylogenetic point of view, along with their geographic distribution. Other descriptive analyses focus on the extraction types, plant tissues and the most targeted bacteria. Species investigated in clinical trials and those tested against the greatest number of bacteria are also presented. A statistical analysis of the MIC values found for each plant extract was performed based on botanical families, extraction types, plant tissues and species (including fractions and EOs). Lastly, we take an in-depth look into the reported antibacterial activities of 70 plant species from the top 15 reported plant families.
Phylogenetic, Taxonomic and Geographic Diversity Among Antibacterial Plants
A total of 958 plant species were investigated for antibacterial activity, representing approximately 0.3% of roughly 308,312 known vascular plant species (). Species studied came from 142 families and 562 genera, representing 30% of the 466 known vascular plant families. Lamiaceae (n = 108 species), Fabaceae (n = 93), Asteraceae (n = 76), Myrtaceae (n = 37) and Anacardiaceae (n = 33) were the top five families according to the number of species investigated (Figure 3A). All of these families, except for Anacardiaceae, belong to the top 10 largest botanical families worldwide with a range of 5,900 to 25,040 known species (Stevens, 2001). Acacia (n = 19 species), Cinnamomum (n = 15), Salvia (n = 11), Teucrium (n = 11) and Thymus (n = 11) were the five genera with the most species investigated for antibacterial activity (Figure 3B). Of the 958 plant species, 16 were studied in at least five different publications, among which Cinnamomum verum J. Presl, Lauraceae (n = 13 publications), Rosmarinus officinalis L., Lamiaceae (n = 10), Thymus vulgaris L., Lamiaceae (n = 10), Origanum vulgare L., Lamiaceae (n = 9) and Mentha piperita L., Lamiaceae (n = 8) were the five most studied (Figure 3C). The fact that all these five most studied species are common herbs or spices could indicate either the overlap of food and medicine in traditional medical systems or the easy accessibility of food plants for scientific study.
FIGURE 3
The 142 families tested for antibacterial activity are spread throughout the phylogenetic tree (Figure 4). Antibacterial activity has been reported in 1% of fern and fern allies (n = 4), 31% of gymnosperm families (n = 4) and 45% of early angiosperm and magnoliid families (n = 13). Only 0.2% of monocot families are reported with antibacterial activity (n = 16). Antibacterial activity is reported in 32% of eudicots families (n = 105), with over 21% of all species reported belonging to the asterid clade. Overall, the percentage of studied species was less than 2%, except in Combretaceae and Anacardiaceae (4%). Higher percentages of studied genera typically indicate smaller families with fewer genera. However, Anacardiaceae (25%), Lamiaceae (17%) and Myrtaceae (12%) show higher percentages of genera studied compared to the total number of genera per family (Figure 4). Widely distributed plant taxa are more represented throughout the tree than geographically restricted taxa, supporting the theory that widely distributed taxa have accumulated more genes for defensive secondary metabolites and are therefore good sources of antibacterial agents (Wink, 2003). However, overall some clades are well represented, while others are poorly investigated.
FIGURE 4
The 958 plant species represented in the dataset were collected in seventy-three countries. South Africa, Cameroon, Brazil, India and Iran were the top five countries according to the number of species investigated (Figure 5).
FIGURE 5
Other Descriptive Analyses
Ailment Categories and Plants in Clinical Trials
The use of plants in traditional medicine was a guiding factor for the majority of the studies in this review. Out of 483 publications on antibacterial plant extracts, 349 (72.3%) discussed the ethnomedicinal uses of the plants being studied. Among categories of traditional medical use, these species were mostly applied in therapies supportive of general (32.5%), gastrointestinal (30.9%) and dermatological (22.0%) health (Figure 6).
FIGURE 6
Of the 958 plant species studied, 97 have been tested in clinical trials (Supplementary Material S2.2). This includes 72 species used in human food. Of the 258 clinical trials testing 59 plant species against infectious or inflammatory diseases, 78 trials (30%) were focused on oral health conditions such as periodontitis, gingivitis and dental caries, and 60 (23%) were focused on respiratory problems such as colds and rhinitis.
Plant Tissue and Extract Types
Of the 1,700 plant extracts investigated under our search parameters, 597 (35.1%) were from leaves and a further 199 (11.7%) were from aerial parts. The next most common plant tissues used were roots, bark and fruit (Figure 7A). Of the 1,700 extracts in the data set, crude methanolic extracts were the most represented with 402 extracts (23.7%), followed by crude ethanolic extracts with 323 extracts (19.0%) and EO with 285 extracts (16.8%) (Figure 7B).
FIGURE 7
Bacteria Targeted
Of the 4,943 MIC values reported under our search criteria, the most targeted bacterial genus by far was Staphylococcus with 1,233 MIC values (25.0%), followed by Bacillus with 479 (9.7%) and Escherichia with 476 (9.6%). The most targeted species was Staphylococcus aureus (n = 1,028 extracts tested), followed by Escherichia coli (n = 476), Pseudomonas aeruginosa (n = 318) and Klebsiella pneumoniae (n = 259) (Figure 8). Four out of six “ESKAPE” pathogens—six pathogens with growing multidrug resistance and virulence: Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp. ()—are represented in the 20 most targeted bacteria; less targeted in the study range are A. baumannii (n = 27) and Enterococcus faecium (n = 8). Of the urgent and serious bacterial threats listed in the U.S. Centers for Disease Control (CDC) 2019 Antibiotic Resistance Threats report (), nine species are represented in the 20 most targeted bacteria (not necessarily resistant strains) and three species are less targeted: Clostridioides difficile (n = 2), Neisseria gonorrhoeae (n = 20) and Streptococcus pneumoniae (n = 27).
FIGURE 8
Minimum Inhibitory Concentration Analyses
To determine quantitative differences in antibacterial activity associated with characteristics of the plant extracts in the study range, MIC values were grouped and analyzed by plant family, plant species, extraction type and plant tissue.
Minimum Inhibitory Concentration Analysis by Plant Families
The 15 most represented plant families by number of species in the study range (Anacardiaceae, Annonaceae, Apiaceae, Apocynaceae, Asteraceae, Combretaceae, Euphorbiaceae, Fabaceae, Lamiaceae, Lauraceae, Malvaceae, Myrtaceae, Rubiaceae, Rutaceae and Zingiberaceae) were further analyzed for their antibacterial activity. All data except those dealing with EOs were included in the initial analysis (3,498 MIC values), and a secondary analysis was carried out with Gram-positive bacteria only (1,944 MIC values) or Gram-negative bacteria only (1,541 MIC values) (Figure 9). EOs were analyzed separately due to the prevalence of a different unit (volume per volume μL/mL, instead of weight per volume μg/mL) in the reporting of their MIC values. Further descriptive statistics are available in Supplementary Material S2.3.
FIGURE 9
The Zingiberaceae, Rutaceae, Myrtaceae, Lauraceae and Rubiaceae families showed the lowest overall mean MICs of the top 15 families with values ranging from 92–185 μg/mL. Zingiberaceae extracts showed significantly better overall growth inhibitory activity than each of the other top 15 families (p < 0.05).
Minimum Inhibitory Concentration by Extraction Types
From a total of 34 extraction types, the ten most represented types (methanol, ethanol, EO, aqueous, acetone, dichloromethane, ethyl acetate, hexane, fraction and chloroform) were further analyzed for their overall antibacterial activity. MIC data of plants extracted with different solvents were analyzed in three ways: looking at activities against all types of bacteria, Gram-positive bacteria or Gram-negative bacteria (Supplementary Material S2.4). Among solvents used for extraction, ethyl acetate showed the best (lowest) mean MICs, while dichloromethane extracts were the highest (Figure 10). Overall, fractions of plant extracts showed the best (lowest) mean MICs demonstrating the efficiency of the fractionation processes and its importance toward the discovery of new antibacterial agents.
FIGURE 10
Minimum Inhibitory Concentration by Plant Tissue
Of the 88 different plant tissues or groups of tissues studied, the ten most represented (leaf, aerial part, root, bark, fruit, whole plant, seed, stem, stem bark, rhizome) were selected for further analysis. MIC data of plant extracts from different plant tissues were analyzed in three ways: looking at all types of bacteria, Gram-positive bacteria, or Gram-negative bacteria (Figure 11A; Supplementary Material S2.5). For Gram-positive bacteria, mean MIC values from bark extracts were statistically higher than those from aerial part, fruit, leaf, rhizome, root, seed, stem and stem bark extracts (Figure 11B). For Gram-negative bacteria, rhizome extracts showed significantly lower mean MIC values than bark, fruit, leaf, root, seed, stem and whole plant extracts (Figure 11C). This can be explained by the low mean MIC found for species belonging to the Zingiberaceae family, which accounts for 91% (50/55) of the MIC values for rhizome extracts.
FIGURE 11
Minimum Inhibitory Concentration by Species (Crude Extracts)
Of the 739 plant species with extract MIC values measured in weight by volume (µg/mL) and not extracted as EOs, 331 were tested against at least three different bacteria strains from all types, 158 were tested against at least three different Gram-positive bacteria and 155 were tested against at least three different Gram-negative bacteria. Sambucus nigra L. (Adoxaceae), Echinops kebericho Mesfin (Asteraceae), Mikania glomerata Spreng. (Asteraceae), Curcuma longa L. (Zingiberaceae) and Combretum album Pers., (Combretaceae) extracts showed the best overall mean MIC values with values ranging from 3.5–16 μg/mL (Figure 12).
FIGURE 12
Minimum Inhibitory Concentration by Species (Essential Oils)
MIC values for species extracted as EOs and tested against more than three species of bacteria were selected for analysis, with values in weight per volume (µg/mL) and volume per volume (µL/mL) being treated separately. Of the 117 plant species extracted as EOs with weight per volume MICs (Figures 13A–C), Hibiscus surattensis L. (Malvaceae) showed the lowest MIC overall and for Gram-negative bacteria (0.09 μg/mL in both cases). Stachys pubescens Ten. (Lamiaceae) had the lowest MIC for Gram-positive bacteria (3.17 μg/mL). Of the 22 plant species extracted as EOs with volume per volume MICs (Figures 13D–F), Trachyspermum ammi (L.) Sprague showed the lowest MIC overall and for Gram-positive bacteria (0.32 and 0.20 μL/mL respectively). Satureja hortensis L. had the lowest MIC for Gram-negative bacteria (0.35 μL/mL).
FIGURE 13
Discussion
Phylogenetic Distribution of Antibacterial Plants
During the process of evolution, plants coevolved with other organisms to attract pollinators and seed dispersers, or to defend themselves from microbes and herbivores. Chemical diversification of secondary metabolites in different plant lineages is not random, but rather is precisely correlated to this adaptive radiation. The correlation between phylogeny and plant chemistry can offer a predictive approach to drug discovery, enabling more efficient selection of plants for chemical mining. As such, we have examined major clades and address the extent to which they were covered by studies on antibacterial activity.
Examination of the major clades in the phylogenetic tree reveals that the magnoliid clade has been reasonably well studied. Fifty percent of the well-known magnoliid families were studied and 62 species were reported to have antibacterial activity (Figure 4). Magnoliids are early angiosperms, comprising four orders, 18 families, and approximately 10,000 species that face relatively high pressure from herbivory (Turcotte et al., 2014; Mawalagedera et al., 2019); thus this group is characterized by unique aromatic compounds such as sesquiterpenes, isoflavonoids, and benzylisoquinoline alkaloids (e.g., aporphines, aristolochic acids, and bis-benzylisoquinolines) (; ). This suggests that other members in the magnoliids clade, including Piperales, Magnoliales and Laurales could be good candidates for chemical studies. However, less than 1% of species have been examined in each order. Lauraceae, Myristicaceae and Annonaceae are large families in the magnoliid clade; nevertheless, only 42 species (Lauraceae = 26; Annonaceae = 15; Myristicaceae = 1) were reported for antibacterial activity studies under our search criteria, representing ∼0.7% of known species in this clade.
Monocots are the least studied group among angiosperms for antibacterial activity, with only 16 out of 80 monocot families evaluated. There are approximately 60,100 monocot species and only 69 (∼0.1%) were reported to have antibacterial activity. This is not a surprising result because monocots have crystalline calcium oxalate raphides (needle-shaped crystals) () and other physical defensive mechanisms against herbivory that they depend upon rather than chemical defensive mechanisms.
Antibacterial activities were recorded in few of the families in the Basal Eudicots group—11 out of 32 families. Four out of seven families in the Ranunculales were reported to have antibacterial activity (Figure 4). Berberine and a great variety of benzylisoquinolines alkaloids are common in this Ranunculales clade. In total, there are approximately 4,500 species in the Papaveraceae, Menispermaceae, Berberidaceae and Ranunculaceae families, but only 13 species (∼0.3%) were recorded in our search, representing a large source of untapped potential chemical novelty in this group.
In the rosid clade, Sapindales and Myrtales have been studied for antibacterial activity. Sapindales is characterized by gums and resins. Five out of nine families in this group are reported to have high antibacterial activity (Figure 4). The remaining four families are taxonomically recently separated, lesser known small families that are restricted to certain geographic regions. However, these should also be considered for future evaluation. For example, Simaroubaceae is a lesser studied small family (∼110 species) mainly restricted to the tropics, yet it is chemically unique, having distinctive secondary metabolites like quassinoids (a group of natural products classified as triterpenoids) that are not found elsewhere in the order (Waterman, 1993; ). Out of 6,570 known species in the rosid clade, only 75 (∼1.1%) have been reported for their antibacterial activity.
Asterid is the youngest and largest clade of all the angiosperm phylogeny (Wikström et al., 2015), with Lamiales, Apiales, Asterales and Ericales as the prominent plant orders. Among those, Asterales is the largest order of all, containing about 13.6% eudicot diversity (). However, plant species in Asterales were not well represented in antibacterial activity studies. Out of 11 Asterales plant families, Asteraceae is the only family recorded to have antibacterial activity. It is the largest angiosperm plant family with about 25,040 known species, but only 76 species (0.3%) were recorded to have activity under our search parameters. Asteraceae has terpenoids, coumarins, polyacetylenes, and flavonoids with potential therapeutic agents (Panda et al., 2019). Despite the discovery of several important secondary metabolites such as artemisinin and silibinin, little attention has been paid to the other active compounds present in Asteraceae.
Other families in the Asterales are smaller, lesser known and restricted to certain geographical areas. However, Campanulaceae is another family in the Asterales that is distributed worldwide and yet no species in that family were reported in our data set. This may be due to the chemical evolution of the clade: iridoids, characteristic compounds in the asterids clade, have a bitter taste and are emetics for vertebrates. Iridoids play a major role in herbivore preference in asterids to attract or mostly to deter as well as to protect the plant against bacterial and fungal pathogens (). Among asterids, Asterales is one of the orders that does not have iridoids. Ericales and Cornales were the earliest to diversify and are known to have both ellagic acid and iridoid type compounds. Both orders have a number of species with higher antibacterial activity.
Lamiales is the next largest order in the asterids clade, and it contains about 12% eudicot diversity. Out of 25 families in the Lamiales order, all the well-known families are recorded to have antibacterial activity. The remaining 16 families that were not studied are small families, collectively containing fewer than 100 species and mostly restricted to certain geographic areas. Lamiales have about 1,050 genera and approximately 23,700 known species; of these, 0.5% were reported for antibacterial activity in our search. The remaining species within this order have a high potential to exhibit antibacterial activity and should be considered in future studies.
Caryophyllales is a sister to asterids and is characterized by having succulents and carnivorous plants. Out of 38 families, nine were studied for antibacterial activity (Figure 4). Various isoflavonoids and other unique compounds are scattered in this group: flavonol sulfates occur in Plumbaginaceae, Polygonaceae and Amaranthaceae, and sulfated betalains in Phytolaccaceae (). Naphthoquinones, which are considered to be potential antifungal drugs, are also produced by many plants that belong to the Caryophyllales families, including Plumbaginaceae, Droseraceae, Nepenthaceae, Dioncophyllaceae and Polygonaceae (; Rischer et al., 2002; ). Other than Amaranthaceae, Caryophyllaceae and Cactaceae, most families of Caryophyllales are monotypic and restricted to tropical and subtropical regions. However, those families also contain various unique compounds. For example, the Dioncophyllaceae and Ancistrocladaceae families, which consist of lianas found in the tropical rainforests of West Africa and Southeastern Asia, contain naphthylisoquinoline alkaloids, which are exclusively found in these two families and are worth considering in future antibiotic research ().
The Santalales is also a small sister group to asterids. Loranthaceae and Santalaceae are the best known families in this clade, and they are distributed worldwide. Other families are very small with few genera and species. Loranthaceae and Santalaceae are both reported for antibiotic activities (; van Vuuren et al., 2015; ; Voukeng et al., 2017; Thielmann et al., 2019). However, other families in this clade are not as well studied for unique chemistry and bioactivity ().
The Fabales, Fagales, Rosales and Malpighiales are the major orders in the fabid clade. Many families in this clade are characterized by cyanogenic glycosides and ellagic acids. Fabales is one of the biggest orders of all eudicots, containing about 9.6% of eudicot species (). Fabaceae is the largest family with about 19,580 species. While 93 individual species of Fabaceae were reported for antibacterial activities under our study criteria, this represents a relatively small percentage (0.5%) of the total diversity in this family.
Gymnosperms and ferns were poorly investigated. Out of 37 fern families, only four were recorded with antibacterial activity; in each of these four families, a single species was studied. Out of 13 gymnosperm families, four were reported to have antibacterial activity and fewer than five species were studied in richly biodiverse families such as Cupressaceae, Ephedraceae and Pinaceae. Interestingly, some gymnosperm families with known use in traditional medicines such as the resin-rich Araucariaceae and Podocarpaceae were not reported in this data set for antibacterial activity; this may indicate a need for the application of standardized methods for the future antimicrobial assessment of these species.
Geographic Distribution of Antibacterial Plants
South Africa, Cameroon, Brazil, India, and Iran were the top five countries by source of plants examined according to the number of species investigated. There are several factors that may explain the large number of plant species in high-quality antibacterial studies in these top five countries; a strong combination of plant diversity, ethnobotanical tradition and scientific equipment and training is needed to study plant antibacterials on this scale. Additionally, the dataset is small enough that the contributions of individual research groups can be clearly seen.
Influence of Plant Tissue and Extract Types on Minimum Inhibitory Concentration Values
The prevalence of leaves and aerial parts in investigations of plant antibacterials could be due to the ease of collecting these tissues without killing the source plant, allowing for sustainable use. Plants use secondary metabolites to interact with bacteria to various degrees in all of their tissues, promoting beneficial organisms and suppressing pathogens, particularly in the rhizosphere () but also in aerial tissues such as leaves (). However, the profile of secondary metabolites varies between plant tissues, and certain metabolites are concentrated in specific tissues (). In general, annual plants contain high levels of secondary metabolites in their reproductive parts and perennial plants contain high levels of secondary metabolites in their roots, rhizomes and bark (Wink, 2010). The low mean MIC of aerial part extracts—typically from herbaceous species—may therefore be due to the richness of secondary metabolites in the reproductive parts ().
Regarding the choice of solvents for extractions, the prevalence of alcohol parallels its use in many traditional medicine systems. Solvent choice is based on its ability to diffuse into the plant cells, dissolve the secondary compounds and diffuse back out of the cell. For example, water swells the plant cells, allowing for a more complete penetration by the solvent. The wide availability of methanol and ethanol may also account for their prevalent use as extraction solvents.
Water and organic solvents such as methanol, ethanol, acetonitrile, acetone, hexane and dichloromethane are commonly employed in the extraction of bioactive compounds from plants in laboratory studies. Choice of extraction solvent is important because extract yields and resulting biological activities of the plant materials are strongly dependent on the nature of extracting solvent; this is due to the presence of different bioactive compounds of varied chemical characteristics and polarities that may or may not be soluble in a particular solvent (Sultana et al., 2009; ; Metrouh-Amir et al., 2015). For example, we noted that dichloromethane exhibited the worst (highest) MICs of any solvents evaluated; hence, while it is not the most suitable for the extraction of antibacterials from plants, it is still very useful for prefractionation.
On the other hand, significant MIC values observed in essential oils (EOs) resemble the data reported in several studies (; ; ), where the ability of these substances to hamper the growth of a diverse range of human pathogens is described. EOs are concentrated hydrophobic liquids extracted from plants. They contain volatile compounds and are “essential” inasmuch as they contain the “essence” of the plant’s fragrance. In general, the chemical composition of essential oils is relatively complex, with about 20–60 different bioactive components and only two to three major components at a fairly high concentrations (20–70%) compared to other components present in trace amounts. Their most common constituents are terpenes, aromatic and aliphatic compounds (especially alcohols, esters, ethers, aldehydes, ketones, lactones, phenols and phenol ethers) (; ). The phenolic components are chiefly responsible for the antibacterial properties of EOs (); however, there is some evidence that minor components have a critical part to play in antibacterial activity, possibly by producing a synergistic effect between other components (Paster et al., 1995; ), while some exert no activity on their own (; Tariq et al., 2019).
Taxonomic Distribution of Antibacterial Plants
In the following section, we highlight 44 plant species notable for their prominence in traditional medicine or for potent antibacterial activity, selecting representatives from each of the top seven families by number of species studied and ordered as such below. We have elaborated on an additional 26 species from the next nine top families in Supplementary Material S2.6. Refer to Supplementary Material S1 to examine the full dataset with species, extraction tissue and type, as well as specific MICs for reported pathogens. Select examples of bioactive species are depicted in Figure 14 and antibacterial compounds in Figure 15. In most cases, additional in vitro, in vivo and clinical research is still needed to confirm efficacy and safety, as well as to identify the responsible compounds and their respective mechanisms of action.
FIGURE 14
FIGURE 15
Lamiaceae
Of the 108 species from the Lamiaceae family that exhibited antibacterial activity, the ten most active species were Origanum vulgare L., Origanum majorana L., Thymus zygis L., Rosmarinus officinalis L., Thymus vulgaris L., Clinopodium taxifolium (Kunth) Govaerts, Clinopodium vulgare L., Mentha x piperita L., Stachys pubescens Ten. and Ocimum basilicum L. All were extracted as EOs and seven are native to the Mediterranean. Thymus, Origanum and Clinopodium species contain similar compounds and are especially rich in monoterpenes such as α-terpineol (1), carvacrol (2), thymol (3), α-terpinene (4), γ-terpinene (5) and p-cymene (6), which synergize with each other and enhance the antimicrobial efficacy of the complex extract mixture compared to single compounds alone ().
Origanum vulgare (oregano) is an aromatic herb found in Asia, Europe and northern Africa. It is used to treat respiratory problems, digestive disorders, dermatological conditions and various other inflammatory and infectious disorders (Polat and Satıl, 2012; ). EOs exhibited MICs ranging from 0.03–100 μg/mL against Listeria monocytogenes, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pyogenes, Escherichia coli and Acinetobacter baumannii (; Santos et al., 2017; ; Thielmann et al., 2019). Compounds 2 and 3 are the two main constituents responsible for the antibacterial activity of oregano EO (). In vivo studies using mouse burn wounds infected with methicillin-resistant Staphylococcus aureus (MRSA) showed a significant reduction of bacterial load () and an oregano-based ointment has been developed to target bacterial species including MRSA ().
Origanum majorana (sweet marjoram) is a perennial herb native to the Mediterranean countries. It is traditionally used to treat asthma, indigestion, headache, insomnia and rheumatism in traditional medicine (). EOs of the flowering aerial parts inhibit E. coli (MIC = 0.19 μg/mL) and S. aureus (MIC = 6.25 μL/mL) (Vaillancourt et al., 2018; ). The antibacterial activity of marjoram EO has been associated with the high proportion of monoterpenes such as 1, 4, 5, 6, and terpinen-4-ol (7) and in a lesser manner with the presence of 2 and 3 ().
Thymus vulgaris (thyme) is an aromatic shrub from the Mediterranean. The aerial parts are used in the traditional treatment of respiratory problems such as cough, bronchitis, laryngitis and sore throat (). EOs exhibited MICs ranging from 0.3–30 μg/mL against Bacillus cereus, E. coli, L. monocytogenes, Salmonella typhimurium and Legionella pneumophila, and 0.78 μL/mL against S. aureus (; ; ; Vaillancourt et al., 2018). The main constituents of thyme EO are 2 and 3, as well as the active monoterpene compounds 5 and 6 ().
Thymus zygis (red thyme) is an endemic species in the Iberian Peninsula. An EO of the flowering herb exhibited MICs of 100 μg/mL against S. aureus and a range of 0.19–400 μg/mL against three strains of E. coli (; Thielmann et al., 2019). There are different chemotypes rich in 3 and linalool (8) (Rota et al., 2008). The variation of the antibacterial activity within the plant species could be explained by the presence of different chemotypes.
Rosmarinus officinalis (rosemary, Figure 14E) is a shrub native to the Mediterranean traditionally used as a pulmonary antiseptic, choleretic, stomachic and antispasmodic (Nejad et al., 2013). It was also reported to treat urinary tract infections, leishmaniasis, other microbial infections and inflammation (). EOs of the aerial parts exhibited MICs ranging from 0.3–1.6 μg/mL in Staphylococcus epidermidis, S. aureus and E. coli, and a range of 7–70 μg/mL in L. monocytogenes, P. aeruginosa and Legionella pneumophila (; ; Santos et al., 2017; ). Limonene (9), camphor (10), eucalyptol (11), α-pinene (12), Z-linalool oxide and borneol (13) are among the major EO constituents which are responsible for antibacterial activity (; ). Ethanol extracts also demonstrated MICs ranging from 70–350 μg/mL against Staphylococcus saprophyticus, S. epidermidis, Enterococcus faecalis and P. aeruginosa (Petrolini et al., 2013). The presence of diterpenes such as carnosic acid (14) and carnosol (15) as well as the phenolic rosmarinic acid (16) have been reported to be directly involved in the antibacterial activity (). A phytotherapeutic drug, Canephron, which contains R. officinalis, Levisticum officinale W.D.J.Koch (Apiaceae) and Centaurium erythraea Rafn (Gentianaceae), demonstrated safety and efficacy in the treatment of urinary tract infections in a meta-analysis of 17 clinical studies (Naber, 2013). Another clinical trial evaluating the efficacy of a mouthwash containing hydroalcoholic extracts of Zingiber officinale Roscoe (Zingiberaceae), R. officinalis and Calendula officinalis L. (Asteraceae) was effective and safe in patients with gingivitis, and its efficacy was comparable to that of chlorhexidine mouthwash ().
Mentha x piperita (peppermint) is a hybrid of Mentha spicata (spearmint) and Mentha aquatica L. (watermint). M. x piperita is a small herb native to the Mediterranean and cultivated all over the world. It is traditionally used to treat a wide range of disorders including skin irritation, sun burns, sore throat, fever, muscle aches, nasal congestion, indigestion and infectious diseases (; Zpetkeviciute et al., 2010; Ouelbani et al., 2016). EOs exhibited MICs ranging from 0.5–8 μg/mL in Staphylococcus aureus, Streptococcus pneumoniae, P. aeruginosa, E. coli, Salmonella typhi and Klebsiella pneumoniae (). Monoterpenes such as menthol and menthone have been reported as responsible for the antibacterial activity (Tyagi and Malik, 2011). An in vivo study showed that ointments from EO improved the healing process in a wound-infected model with S. aureus and P. aeruginosa (Modarresi et al., 2019). Several clinical trials have investigated the efficacy and safety of M. x piperita, but most of these focused on non-infectious disorders such as irritable bowel syndrome and non-ulcer dyspepsia (McKay and Blumberg, 2006).
Salvia officinalis L. (sage) is an aromatic herb native to the Mediterranean used traditionally to treat ulcers, gout, rheumatism, diarrhea, dyspepsia and inflammation in the skin and throat (Vokou et al., 1993; ). EOs exhibited MICs ranging from 12.5–225 μg/mL against S. aureus, L. monocytogenes, E. coli and P. aeruginosa (; Santos et al., 2017; Vaillancourt et al., 2018). Ethanol extracts exhibited MICs of 62.5 and 300 μg/mL against Streptococcus pyogenes and Staphylococcus aureus, respectively (Silva et al., 2019; Wijesundara and Rupasinghe, 2019). Z-linalool oxide, 9, 10, 12, and 13 are the main constituents responsible for the EO antibacterial activity (), while 16, 24, 26, ursolic acid, epigallocatechin gallate, and chlorogenic acid could be involved in the antibacterial activity of the alcoholic extract ().
Ocimum basilicum (basil) is traditionally used to treat headaches, coughs, diarrhea, warts and digestive disorders (; ; ). EOs of the aerial parts exhibited MICs ranging from 0.6–50 μg/mL against Salmonella typhimurium, Vibrio cholerae and Streptococcus pyogenes, while the methanol extract of its seeds exhibited an MIC of 25 μg/mL against Mycobacterium tuberculosis (; Ozdikmenli and Demirel Zorba, 2015; Snoussi et al., 2016; ). The main constituent in O. basilicum EO is 8, it is thought to be largely responsible for its antibacterial activity, but seasonal variations of its concentration could lead to reduced antibacterial effects in summer (). Bioactive phenolics such as 16, chicoric acid and caftaric acid might be responsible for the antibacterial activity in the methanol extract ().
Fabaceae
Of the 93 Fabaceae species exhibiting antibacterial activity, the ten most active were Dichrostachys cinerea (L.) Wight & Arm., Albizia myriophylla Benth., Glycyrrhiza triphylla Fisch. & C.A.Mey., Copaifera reticulata Ducke, Acacia karroo Hayne, Albizia gummifera (J.F.Gmel.) C.A.Sm., Glycyrrhiza glabra L., Calpurnia aurea (Aiton) Benth., Copaifera paupera (Herzog) Dwyer and Copaifera publifora Benth.
Dichrostachys cinerea is a shrub native to Africa. Its twigs are used in traditional treatments for acne vulgaris, while leaves and fruits are used for the treatment of diarrhea, fever and headache (Shandukani et al., 2018). Twigs of D. cinerea extracted with dichloromethane and methanol (1:1) had an MIC against Staphylococcus epidermidis of 0.19 μg/mL (Nciki et al., 2016); however, in the same study, no activity was found on eight other bacterial pathogens tested.
Albizia myriophylla is a liana which is mainly found in Southeast Asia. Its leaves, roots, flowers and wood are traditionally used in the treatment of fever, wounds, constipation, earache, digestive disorders, cough and oral diseases (Saralamp, 1996; ). The wood ethanol extract had an MIC of 3.9 μg/mL against the oral pathogen Streptococcus mutans. Lupinifolin (17) was found to be responsible for this activity by damaging cell membranes, resulting in cell leakage ().
Glycyrrhiza glabra (licorice) is a widely used medicinal plant native to southern Europe and some parts of Asia. In traditional Chinese medicine (TCM), it is used for arthritis, bronchitis, cough, fatigue, spasms and pain (). It is also considered an “assistant drug” in TCM as it enhances the effectiveness of other ingredients in herbal formulations (Wang et al., 2013). In Ayurveda, it is used to relieve inflammations, eye diseases, throat infections, peptic ulcers, arthritis and liver conditions (; ). The stem methanol extract exhibited an MIC of 10 μg/mL against P. aeruginosa () while the root ethanol extract demonstrated an MIC of 62.5 μg/mL against Streptococcus pyogenes (Wijesundara and Rupasinghe, 2019). Its antibacterial activity is mainly attributed to flavonoids such as glabridin (18), glabrol, glabrene, hispaglabridin A, hispaglabridin B, 4-O-methylglabridin and 3-hydroxyglabrol (Pastorino et al., 2018). An in vivo pharmacodynamic evaluation of a liposomal dry powder for inhalation containing licorice extract showed significant reduction in bacterial counts in the lungs and spleen of Mycobacterium tuberculosis-infected mice (Viswanathan et al., 2019).
Glycyrrhiza triphylla is a plant growing in Afghanistan, Iran, Pakistan and Turkmenistan. The aerial part EO exhibit MICs ranging from 2.7–44 μg/mL for Micrococcus luteus, Listeria monocytogenes, Pseudomonas aeruginosa and S. aureus and 87 μg/mL for Bacillus cereus and Salmonella typhi (Shakeri et al., 2017). The main constituents, 9, β-caryophyllene (19), β-myrcene and α-humulene, have been reported to have antibacterial activity. In contrast with G. glabra, G. triphylla is a poorly studied plant species, needing further investigation.
Trees from the genus Copaifera (copaiba trees) are widely distributed in the northern part of South America. Oleoresins from copaiba are known for their bactericidal, anti-helminthic, anti-inflammatory and analgesic activities (Plowden, 2004; ). C. reticulata oleoresin exhibited MICs ranging from 6–25 μg/mL against the oral pathogens Porphyromonas gingivalis, Streptococcus mitis, S. salivarius and S. sanguinis and a range of 25–100 μg/mL for other pathogens: L. monocytogenes, Staphylococcus aureus and Enterococcus faecalis (; ; Vieira et al., 2018). Diterpenes such as ent-kaurenoic acid (20), kolavenic acid (13E)-ent-labda-7,13-dien-15-oic acid and ent-polyalthic acid have been reported to be responsible for the antibacterial activity of the oleoresin (Pfeifer Barbosa et al., 2019). C. paupera is another tree from the “copaiba” group. Its oleoresin inhibited growth of L. monocytogenes, Bacillus cereus and S. aureus at MICs ranging from 12.5–100 μg/mL (). Copalic acid, ent-polyalthic acid, and 20 may be responsible for the activity observed in vitro (Tincusi et al., 2002). Likewise, C. publifora oleoresin showed antibacterial activity against a number of pathogens ().
Acacia karroo is a tree distributed throughout southern Africa. The gum is used to treat abscesses, oral disorders and osteomyelitis, while the bark is employed for the treatment of colds, diarrhea, dysentery, flu, hemorrhage, ringworm and stomachache and the root is used for genitourinary disorders such as gonorrhea, syphilis, urinary schistosomiasis and venereal diseases (Maroyi, 2017). A methanol extract of aerial parts showed growth inhibitory activity against S. aureus, Micrococcus luteus and Pseudomonas aeruginosa, with MICs ranging from 7.5–125 μg/mL. Methanol extracts of the stems exhibited MICs of 78–156 μg/mL against ampicillin-resistant Klebsiella pneumoniae, MRSA and beta-lactamase producing E. coli (; Nielsen et al., 2012). Activity has been attributed to β-sitosterol (21) and epigallocatechin (22) (Nyila et al., 2012).
Asteraceae
Of the 76 species from the Asteraceae family with antibacterial activity, the ten most active species were Tanacetum polycephalum Sch.Bip., Xanthium strumarium L., Echinops kebericho Mesfin, Cota palaestina Reut. ex Unger & Kotschy, Mikania glomerata Spreng., Artemisia abyssinica Sch.Bip. ex A.Rich., Matricaria chamomilla L., Rhanterium suaveolens Desf., Litogyne gariepina (DC.) Anderb. and Achyrocline satureioides (Lam.) DC.
Tanacetum polycephalum is an aromatic plant mainly distributed across Iraq, Iran and Turkey, where it is traditionally used to treat respiratory tract infections, arthritis, psoriasis, headache, migraines and diabetes (). The aerial part EO exhibited MICs of 0.36–10 μg/mL against Staphylococcus aureus, Bacillus subtilis, Escherichia coli and Salmonella typhi (Rezazadeh et al., 2014). Compounds 10, 11, 13, and isomenthol are the four main compounds likely responsible for the antibacterial activity.
Xanthium strumarium (cocklebur) is an herbaceous plant widely distributed across the world. It is used to treat bacterial and fungal infections, diabetes, skin pruritus, allergic rhinitis and rheumatoid arthritis (). Leaf EO demonstrated MICs ranging from 0.5–20.5 μg/mL against S. aureus, B. subtilis, Klebsiella pneumoniae and Pseudomonas aeruginosa (Sharifi-Rad et al., 2015). Two of the EO main constituents, 9 and 13, may be responsible for the antibacterial activity.
Echinops kebericho is a plant endemic to Ethiopia. The root is traditionally used to treat fever, headache, stomachache, malaria and cough (). Ethanol and methanol extracts of the root exhibited MICs of 3–25 μg/mL against S. aureus, Enterococcus faecalis and E. coli. A major constituent, dehydrocostus lactone, is a sesquiterpene lactone that has demonstrated antibacterial activity ().
Cota palaestina is an herbaceous plant distributed in different regions of Jordan used traditionally as a diuretic and antiedemic (). The EO of the flowers showed MICs of 6–25 μg/mL against Staphylococcus epidermidis, S. aureus and B. subtilis and 53 and 75 μg/mL for E. coli and P. aeruginosa, respectively (). Sesquiterpenes such as spathulenol, germacrene D (23) and caryophyllene oxide may be involved in the antibacterial activity.
Mikania glomerata is a vine native to Southeastern Brazil and cultivated in several South American countries. The leaves are used to treat snake bites, fevers, stomach discomfort, rheumatism and respiratory problems (Napimoga and Yatsuda, 2010). The methanol extract of the plant exhibited MICs against Cutibacterium acnes (6.25 μg/mL) and E. faecalis (25 μg/mL) as well as against oral pathogens at a range of 12.5–18 μg/mL: Actinomyces naeslundii, Porphyromonas gingivalis and Prevotella nigrescens (Moreti et al., 2017). Its major constituent 20, a diterpene, has been reported to be responsible for the antibacterial activity (Moreira et al., 2016). A clinical trial evaluating the efficacy of a mixture of M. glomerata and Mikania laevigata Sch.Bip. ex Baker in the disinfection of toothbrushes used by preschool children showed a reduction of Streptococcus mutans similar to that with chlorhexidine ().
Artemisia is well known due to the discovery of new antimalarial agents (artemisinin and its derivatives) in the 1970s in the species Artemisia annua (Tu, 2016). Since then, Artemisia species have been widely investigated as a source of antimicrobial compounds. Five different Artemisia species have been reported to exhibit antibacterial activity including A. abyssinica, A. indica Willd., A. vestita Wall. ex Besser, A. herba-alba Asso and A. fragrans Willd. The two most active species are discussed here. A. abyssinica is an herbaceous plant distributed throughout Africa and the Middle East. It is used to treat cough and respiratory disorders as well as constipation and rheumatism (). A leaf methanol extract exhibited MICs of 6.25 and 12.5 μg/mL against Mycobacterium tuberculosis and M. bovis, respectively (). An EO of A. indica, a species native to Asia, exhibited MICs of 32–128 μg/mL against Gram-negative bacteria such as K. pneumoniae, P. aeruginosa, Salmonella typhi and Shigella dysenteriae and activity was attributed in part to a major constituent, artemisia ketone (Rashid et al., 2013). More generally, the presence of 10, 11, and artemisia ketone in Artemisia species might explain their antibacterial activity ().
Matricaria chamomilla (chamomile) is an herb native to southern and eastern Europe. Traditionally, it is used to treat coughs, menstrual and gastrointestinal pains, rheumatism, eczema, skin irritations, gingivitis, and eye inflammations (Vitalini et al., 2015). Its EO showed MICs of 10–156 μg/mL against E. coli, K. pneumoniae, Proteus mirabilis, P. vulgaris, MRSA and B. subtilis (). α-bisabolol could be involved in the antibacterial activity observed (Romero et al., 2012). A topical application of Ad-Muc®, a M. chamomilla formulation, demonstrated faster wound healing than corticosteroids on tongue ulcers in a mouse model (Martins et al., 2009). In clinical studies, a wild chamomile mouthwash infusion administered to a patient with methotrexate-induced oral mucositis successfully treated the patient within 4 weeks (Mazokopakis et al., 2005), and the efficacy of M. chamomilla on oral mucositis was confirmed in a clinical trial evaluating 98 head and neck cancers treated with a chamomile oral rinse (Petronilho et al., 2012).
Myrtaceae
Of the 37 species belonging to the Myrtaceae family with reported antibacterial activity, the ten most active were Rhodomyrtus tomentosa (Aiton) Hassk., Eucalyptus camaldulensis Dehnh., Syncarpia glomulifera (Sm.) Nied., Corymbia torelliana (F.Muell.) K.D.Hill & L.A.S.Johnson, Myrtus communis L., Syzygium cordatum Hochst. ex Krauss, Melaleuca armillaris (Sol. ex Gaertn.) Sm., Eugenia brevistyla D.Legrand, Eugenia catharinae O. Berg., Eucalyptus globulus Labill. and Psidium guajava L. Half of these plant species are native to Australia (i.e., E. camaldulensis, S. glomulifera, C. torelliana, M. armillaris and E. globulus). Here, we focus on the five most represented species by number of publications: Psidium guajava, Rhodomyrtus tomentosa, Eucalytpus camaldulensis, Eucalytpus globulus and Syzygium aromaticum (L.) Merr. & L.M.Perry.
Psidium guajava (guava) is a pantropical tree native to Central and South America. One of the main traditional uses of P. guajava is as an antidiarrheal (). Other medicinal uses include the treatment of bacterial infections, coughs, diabetes, dysentery, fevers, leucorrhea, rheumatism, toothaches and wounds (). Methanol extracts of leaves showed MICs of 31–128 μg/mL against Staphylococcus aureus, Pseudomonas aeruginosa and Enterobacter aerogenes. Acetone extracts of the leaves exhibited MICs of 78 μg/mL on Salmonella typhi, Enterococcus faecalis and Shigella flexneri (; ; ). A mixture of flavonoids (including quercetin (24), quercetin derivatives, kaempferol, avicularin, guaijaverin and morin glycosides) is likely to be responsible for the antibacterial activity (; Sanches et al., 2005). Various in vivo models were used to evaluate the effect of guava on infectious diarrhea. This includes Citrobacter rodentium-infected mice, which showed quicker clearance of infection after 19 days with an hydroalcoholic extract of P. guajava given at 300 mg/kg/day (), and V. cholerae-infected mice which demonstrated intestinal ameliorative effects after 4 h infection when treated with an ethanol extract of P. guajava leaves at 250 mg/kg (Shittu et al., 2016). A randomized double-blind clinical trial was performed to evaluate the efficacy of the phytodrug QG5®, containing P. guajava leaves with a standardized concentration of flavonoids, on patients with infectious gastroenteritis. QG5® significantly reduced the duration of abdominal pain in these patients with no serious adverse effects ().
Rhodomyrtus tomentosa is an evergreen shrub native to Southeast Asia. The berries, leaves and stems of R. tomentosa are traditionally used to treat diarrhea, wound infections and traumatic hemorrhage (Ong and Nordiana, 1999; ). The leaf ethanol extract exhibited MICs of 7.8–32 μg/mL against Gram-positive bacteria such as Bacillus cereus, S. aureus (including MRSA), Streptococcus mutans, S. agalactiae and Listeria monocytogenes (Phoem and Voravuthikunchai, 2012; ; Odedina et al., 2015; Na-Phatthalung et al., 2017; Zhao et al., 2019). Rhodomyrtone (25), an acylphloroglucinol, is responsible for the antibacterial (bactericidal) activity against Gram-positive bacteria but is not active against Gram-negative bacteria (). Tomentosone C, another acylphloroglucinol, could also be involved in the antibacterial activity (). The ethanol extract has demonstrated activity in Staphylococcus aureus infections in in vivo models of bovine mastitis, and it also reduced the mortality rate of Streptococcus agalactiae-infected Nile tilapia (Na-Phatthalung et al., 2017; Mordmuang et al., 2019).
Trees from the Eucalyptus genus are native to Australia and are widely distributed throughout the world. The red gum from E. camaldulensis was directly applied to abrasions and cuts by Australian Aboriginal peoples (; ), and in Africa, the gum is used to treat diarrhea and sore throat, while the leaves are used to treat respiratory problems (). A stem bark hexane extract and leaf extract exhibited an MIC of 4 and 6.25 μg/mL against Mycobacterium tuberculosis, respectively (). The leaf EO exhibited MICs at 5 μL/mL against Escherichia coli, Shigella spp. and Bacillus spp. (Nasir et al., 2015). Quercitrin, naringenin, kaempferol, 24, and ellagic acid (26) might play a role in the antibacterial activity for non-EO extracts, while 1, 2, 3, 5, 6, 7, 11, 12 are likely to play a role in leaf hydrodistillates (). In a study of 100 individuals, toothpaste with E. camaldulensis EO (0.8 mg/mL) exhibited a significant reduction of dental biofilm after 4 weeks over that of the positive control formulation containing 0.2% chlorhexidine (2 mg/mL) (Rasooli et al., 2009).
Eucalyptus globulus leaves are widely used to treat respiratory problems (). A leaf ethanol extract exhibited MICs of 125 and 250 μg/mL against Mycobacterium smegmatis and M. ulcerans, respectively (Tsouh Fokou et al., 2016). Its EO inhibited growth of E. coli, Streptococcus iniae and Staphylococcus aureus (Roomiani et al., 2013; ; Thielmann et al., 2019). The main constituents of E. globulus EO, 11 and 12, are likely to be responsible for the EO activity (), while phenolic compounds might be involved in the activity of ethanol extracts (). Eucalyptus oil has been approved for use by the US Food and Drug Administration and many over-the-counter (OTC) products include it in their formulations (). It is also recommended as a steam inhalation for treating chronic sinusitis (). The European Medicines Agency noted a paucity in clinical data on its efficacy, but the presence of 11 supports action on upper respiratory diseases. However, precautions should be taken as side effects can occur (e.g., allergic reactions, nausea and vomiting) and the inhalation and cutaneous use of eucalyptus EOs among young children (<30 months) can lead to laryngospasm ().
Syzygium aromaticum (clove) is a tree native to Indonesia. The EO of its buds is widely used in dental care as an antiseptic and analgesic (Rosas-Piñón et al., 2012). Other traditional uses include the treatment of cuts and wounds. The bud EO exhibited MICs of 50, 100 and 400 μg/mL against Haemophilus ducreyi, S. aureus and E. coli, respectively. Leaf EO demonstrated MICs of 250–500 μg/mL against dental pathogens such as Fusobacterium nucleatum, Porphyromonas gingivalis and Streptococcus mitis (; ; Thielmann et al., 2019). Eugenol (27), a phenolic compound, is the main EO constituent with a concentration ranging from 47.64 to 88.58% (). It has demonstrated antibacterial activity through membrane cell lysis and leakage of proteins and lipid contents (). Eugenyl acetate, benzyl alcohol and 19 are other compounds present in the plant with antibacterial activity.
Anacardiaceae
A total of 33 species of Anacardiaceae were investigated for their antibacterial properties. Four percent of the species present in Anacardiaceae were investigated, the highest percentage of any family. The five species with the lowest MICs were Anacardium occidentale L. (Figure 14C), Schinus terebinthifolia Raddi, Pistacia terebinthus L., Mangifera indica L. and Pistacia lentiscus L.
Anacardium occidentale (cashew) is a large tropical evergreen tree native to Central America, South America and the Caribbean Islands, but it has now spread throughout Southeast Asia and Africa. The cashew apple is a fleshy fruit, the pulp of which can be processed into drinks or distilled into liquor. In India, cashew fruits are used to treat asthma and headache, while cashew seeds are used for burns and male fertility (Morvin Yabesh et al., 2014). The leaves and bark of A. occidentale are used for malaria in Nigeria () and for diarrhea and fever in Peru (Odonne et al., 2013). The aqueous bark extract exhibited MICs of 3–6 μg/mL against oral pathogens such as Streptococcus mitis, S. mutans and S. salivarius (). The leaf methanol extract exhibited MICs of 7.5–15 μg/mL against Enterococcus faecalis, Staphylococcus aureus and Micrococcus luteus (). Phenolic compounds such as anacardic acids, cardols and quercetin glycosides are suspected to be responsible for the activity (Tan and Chan, 2014; ). In a randomized clinical trial, a mouthwash containing stem bark EO diluted in ethanol (10%) showed similar results on the reduction of plaque formation and gingival bleeding after 30 days as a mouthwash with chlorhexidine (0.12%) ().
Schinus terebinthifolia (Brazilian peppertree) is a spreading shrub or small tree native to subtropical and tropical South America; it is an invasive weed in Florida (Williams et al., 2005). It is used to treat inflammatory, dermatological and hemostatic diseases (Salem et al., 2018). An acetone extract of the fruits exhibited MICs ranging from 8–16 μg/mL for Acinetobacter baumannii, S. aureus and Escherichia coli. The fruit EO exhibited an MIC of 32 and 128 μg/mL against Pseudomonas aeruginosa and Micrococcus flavus, respectively (Salem et al., 2018). A fruit extract significantly reduced dermonecrosis following skin challenge in mice infected with a virulent MRSA strain, though this activity was credited to anti-virulence rather than growth inhibitory effects (Muhs et al., 2017), with triterpenoid acids being responsible for the activity (Tang et al., 2020).
Pistacia terebinthus is a tree widely distributed in the Middle East and the Mediterranean region. It is used to treat asthma, bronchitis, burns, cold, leprosy and urinary afflictions (). The fruit, galls and leaves extracted as EOs exhibited MICs against MRSA strains at 0.32, 0.64 and 1.28 μL/mL, respectively. The main compounds in these EOs are 9, 12, and β-pinene (Pulaj et al., 2016).
Pistacia lentiscus (mastic) is an evergreen shrub or small tree that grows up to 4 m tall and is native throughout the Mediterranean region and the Canary Islands; it is cultivated elsewhere for its aromatic resin. It is used to treat stomachache and urinary afflictions in Turkey () and as an antiprostatitic, antiseptic and hypotensive in the Iberian Peninsula (). Mastic gum is a natural resin derived from the stem and leaves, and it is traditionally used to treat gastrointestinal ailments (). The EO of the aerial parts was active against MRSA (MIC = 120 μg/mL) (); 9, 12, myrcene, and β-pinene might be involved in the activity (). An in vivo study showed that mastic gum from P. lentiscus var. chia reduced Helicobacter pylori colonization in mice over a period of 3 months and that triterpenoid acids may be responsible for the activity (Paraschos et al., 2007).
Mangifera indica (mango) is a tree native to tropical Asia that now grows in most tropical countries. Mango bark is used for the treatment of cough, diarrhea, gastric disorders, syphilis and urinary tract disorders. The leaves are used to treat bronchitis, colds, diarrhea, fever, malaria and wounds (). A bark methanol extract was active against P. aeruginosa (MIC = 32 μg/mL), while a methanol leaf extract exhibited an MIC of 125 μg/mL against P. aeruginosa and 250 μg/mL against S. aureus; a leaf hexane extract had an MIC of 250 μg/mL against Mycobacterium smegmatis (; Tsouh Fokou et al., 2016; ). Mangiferin, a xanthone, as well as gallotanins, kaempferol and 24, might be responsible for the antibacterial activity (; ). A mango leaf extract carbopol hydrogel formulation showed in vitro and ex vivo antibacterial activity against S. aureus ().
Rubiaceae
Rubiaceae is well-known as the family of Cinchona spp., the source of quinine and other anti-malarial alkaloids (). A total of 33 species from the Rubiaceae family were studied for antibacterial activity, mainly as antimycobacterials: 54.4% MIC values reported for extracts from Rubiaceae were against Mycobacterium spp. The species with the best activity from this family were Pavetta lanceolata Eckl. and Cephalanthus natalensis Oliv. Sarcocephalus latifolius (Sm.) E.A.Bruce exhibited the best activity against non-mycobacterial species.
Pavetta lanceolata (weeping bride’s bush) is a tree or shrub native to southern Africa. Its leaves are traditionally used as an anti-emetic and the root as a tonic (). A leaf acetone extract inhibited growth of Mycobacterium smegmatis, M. aurum and M. tuberculosis with MICs ranging from 12–120 μg/mL (). However, in vitro cytotoxicity tests with human liver and kidney cells yielded LD50 values of 277 μg/mL and 97 μg/mL, respectively, indicating that toxicity may be a barrier to developing antimycobacterials from P. lanceolata ().
Cephalanthus natalensis (bush berry) is a shrub native to southern Africa. The fruit is eaten and the bark is used to treat bleeding (). The acetone extract of C. natalensis leaves exhibited MICs ranging from 17–170 μg/mL against Micrococcus flavus, Mycobacterium tuberculosis, M. aurum and M. smegmatis (; ). Similar to P. lanceolata, the C. natalensis extract exhibits cytotoxicity in human liver and kidney cells with LD50 values of 138 μg/mL and 76 μg/mL, respectively (). However, a combination of C. natalensis extracts interacted synergistically with the established antimycobacterial rifampicin, achieving a M. tuberculosis MIC with 2.5 μg/mL extract and 2.25 μg/mL rifampicin (Fractional Inhibitory Concentration Index, FICI = 0.31), suggesting that exploiting drug interactions may be a pathway to avoid toxicity ().
Sarcocephalus latifolius is native to West Africa and is traditionally used to treat diarrhea, dysentery and fever (including malaria); it is also used as a chewing stick for oral conditions such as dental caries (Tekwu et al., 2012). A methanol extract of the stem bark was found to have good activity against Gram-negative bacteria, inhibiting growth of Escherichia coli, Salmonella typhi and Shigella flexneri (MIC: 32 μg/mL); the extract was also active against Staphylococcus aureus and Bacillus cereus MICs ranging 64–128 μg/mL (Tekwu et al., 2012). A separate study of S. latifolius stem and bark methanol extract identified six bioactive alkaloids: latifoliamides A-E and angustoline ().
Apiaceae
The Apiaceae family is known to contain aromatic herbs and many poisonous species. Of the 31 species from the Apiaceae family studied as antibacterials, Trachyspermum ammi (L.) Sprague, Coriandrum sativum L. (Figure 14D) and Eryngium spp. exhibited the most activity.
Trachyspermum ammi (ajowan) is an herb native to Iran and India (Moosavi-Nasab et al., 2016). Its fruit is used as a spice and to preserve meat (); an aqueous extract of T. ammi is also used to treat flu in children (Moosavi-Nasab et al., 2016). The fruit EO was found to inhibit growth of Bacillus cereus, Listeria monocytogenes, Staphylococcus aureus, Enterobacter aerogenes, Pseudomonas putida and Escherichia coli with an MIC of 0.4 μL/mL. The major constituents of this EO were 3, 5, and 6 (Moosavi-Nasab et al., 2016).
Coriandrum sativum (coriander) is an annual herb which grows wild mostly in western Asia and southern Europe. C. sativum seeds and leaves are well known for their utility as a seasoning in cooking. In traditional medicine, coriander is used as a stimulant, stomachic, carminative, antispasmodic, diuretic and anthelminthic (Sivasankari et al., 2014) and to treat asthma, cough and bronchitis (). C. sativum EO showed MICs ranging from 0.4–62 μg/mL against E. coli, Proteus mirabilis, Fusobacterium nucleatum and Staphylococcus aureus, S. hyicus and Streptococcus mitis (; ; Vaillancourt et al., 2018). The constituents of C. sativum EO are primarily monoterpenes, with 8, 9, and linalyl acetate being the most prominent (). The proposed antibacterial mechanism of action (MOA) of C. sativum EO is disruption of the cell membrane (Silva et al., 2011). In its wide use as an herb and spice, C. sativum has not exhibited significant toxicity ().
Eryngium is the largest genus in Apiaceae and is found on every continent except Antarctica. Several Eryngium species are used in various traditional medicine practices to treat conditions including hypertension, gastrointestinal distress, diarrhea, burns and fevers (). Five Mediterranean Eryngium species exhibited antibacterial activity including E. amethystinum L., E. campestre L., E. glomeratum Lam., E. palmatum Pančić & Vis. and E. pusillum L. with MICs of 2–500 μg/mL (; Matejić et al., 2018). The EO of E. amethystinum aerial parts exhibited MICs of 2 μg/mL against Staphylococcus aureus and contained 22, α-gurjunene and γ-muurolene. The acetone extract of E. campestre showed MICs of 4–10 μg/mL against Proteus mirabilis, Escherichia coli and S. aureus (Matejić et al., 2018). A 2015 review of the phytochemistry and antimicrobial activity of Eryngium called for toxicity and MOA experiments for the further development of Eryngium extracts as antibacterials ().
Conclusion and Future Directions
We have reported the antibacterial activities of 958 plants by reviewing the literature published from 2012 to 2019, which represents 66% of the total literature on this subject since 1946. Our review was focused to include the literature that followed established guidelines for botanical authentication and biological screening. These numbers of plants and plant natural products, while large, are miniscule in comparison to the 374,000 () estimated total plants, or even the 28,187 medicinal species used by humans (MNPS, 2020). Medicinal plants and their natural products thus remain largely untapped as sources of antibacterial compounds.
We are highly encouraged by the number of highly bioactive extracts identified in this review. Eloff defined an extract or fraction as having significant antibacterial activity if the MIC against the given organism is equal to or less than 100 μg/mL (), and Kuete defined a compound as having significant antibacterial activity if the MIC is equal to or less than 10 μg/mL (). To this extent, we report 358 plant extracts that fall under Eloff’s cutoff for at least one bacterial species. Gibbons defined essential oils as having significant activity if the MIC is equal to or less than 5 μL/mL (). Since the density of essential oils is inferior but close to 1 g/mL, we also considered essential oils with MICs reported in µg/mL as significant if the MIC is equal to or less than 5 μg/mL. To this extent, we report 50 essential oils as having high antibacterial activity against at least one bacterial species. Such observations confirm that plants and their natural products represent promising sources of antibacterials and that their continued exploration represents a productive trajectory.
There are a number of research errors that we commonly encountered in the literature which precluded paper inclusion into our data analysis. Regarding botanical authentication, many publications reported collecting plant material from markets without proper identification, or they did not mention depositing a corresponding herbarium voucher specimen. As stated by previous authors, rigorous assessment of the taxonomic nomenclature of plants should be addressed at an early stage in ethnobotanical surveys (Rivera et al., 2014). From a chemical perspective, researchers should be aware of the information gained from and resolution limitations of thin layer chromatography methods, which can lead to oversimplified conclusions regarding chemistry. Also, the lack of standard methods to evaluate the antibacterial activity of plants is a major concern. In particular, the agar diffusion assay (also known as the disc diffusion method) is not appropriate for the quantitative analysis of plant extracts as non-polar compounds can fail to diffuse and thus lead to false results (Tan and Lim, 2015). Instead, broth microdilution or agar dilution assays should be used for quantifying the antibacterial activity of plant extracts. The CLSI () and other protocols (; ; Sarker et al., 2007; Wiegand et al., 2008) contain precise information on the materials and equipment needed as well as the inoculum density, time of incubation and positive controls to be used. Furthermore, we propose specific cutoffs for therapeutically relevant MIC values be implemented in future work (; ; ). Researchers should also take into consideration the possible toxicity of drugs, employing systematic counterscreening against human cell lines whenever possible ().
Beyond expanding and refining bioprospecting and the in vitro studies addressed above, ethnobotanical antibiotic drug discovery endeavors would benefit greatly from further preclinical studies. Such studies include compound isolation from bioactive extracts, mechanism of action studies, in vivo testing in animal models of infection, structural modification of compounds to improve pharmacodynamics and pharmacokinetics, structure-activity relationship (SAR) analyses, and incorporating emerging trends into the traditional workflow. Also, synergistic interactions within plant extracts and between plant compounds and antibiotics should be further studied to unveil the mechanism beyond the antibacterial activity of these compounds and then discover multiple pathways to be targeted. As an example, Berberis species producing the antibacterial alkaloid berberine are also able to synthesize a compound (5′-methoxyhydnocarpin) responsible for the inactivation of efflux pumps in P. aeruginosa, thus potentiating the antibacterial effect of berberine (Stermitz et al., 2000). Many research groups may build some of these capabilities themselves or collaborate with other groups to share expertise. In particular, international collaborations between resource-rich institutions with scientific partners in biodiversity rich areas of the world can lead to mutual benefits in equitable access and benefit sharing for research teams, government bodies and community partners. Such collaborations allow for biodiversity to be probed more deeply than otherwise possible and result in expertise sharing, research training opportunities for students and faculty and joint publications and patents under the principles of the United Nations Convention on Biological Diversity and the Nagoya Protocol (UN, 2011). Addressing the threat of antibiotic resistance will take a variety of strategies working together, and the ethnobotanical approach offers the tools to unlock and apply the useful chemistry of plants to antibiotic compound discovery.
Funding
This work was supported by the National Institute of Allergy and Infectious Disease (R21 AI136563 to CLQ), Emory University development funds to CLQ, and a graduate student fellowship from The Jones Center at Ichuaway to LM.
Statements
Author contributions
FC and TS have equal contribution as co-first author, CLQ, FC and GP designed the study, FC led the literature search, FC, TS, GP, JTL, MD, LM, AMS, SS, and DRF performed the literature search, TS performed the phylogenetic assessment. All authors completed the data analysis, wrote the manuscript, and approved the final version of the manuscript.
Acknowledgments
We thank Sarah Hanson, Apple Liu, Leah Scott, Emily Edwards, Kat Bagger, and Courtney Andrews for their assistance in the literature search.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fphar.2020.586548/full#supplementary-material.
References
1
AbadM. J.BermejoP.VillarA. (1995). An approach to the genus Tanacetum L. (Compositae): phytochemical and pharmacological review. Phytother Res.9, 79–92. 10.1002/ptr.2650090202
2
AboelsoudN. H. (2010). Herbal medicine in ancient Egypt. J. Med. Plants Res.4, 082–086. 10.5897/JMPR09.013
3
AbolfazlM.HadiA.FrhadM.HosseinN. (2014). In vitro antibacterial activity and phytochemical analysis of some medicinal plants. J. Med. Plants Res.8, 186–194. 10.5897/jmpr12.1298
4
AbreuA. C.CoqueiroA.SultanA. R.LemmensN.KimH. K.VerpoorteR.et al (2017). Looking to nature for a new concept in antimicrobial treatments: isoflavonoids from Cytisus striatus as atibiotic ajuvants against MRSA. Sci. Rep.7, 3777. 10.1038/s41598-017-03716-7
5
AbreuA. C.McbainA. J.SimõesM. (2012). Plants as sources of new antimicrobials and resistance-modifying agents. Nat. Prod. Rep.29, 1007–1021. 10.1039/c2np20035j
6
AgeletA.VallèsJ. (2003). Studies on pharmaceutical ethnobotany in the region of pallars (pyrenees, catalonia, iberian peninsula). Part II. New or very rare uses of previously known medicinal plants. J. Ethnopharmacol.84, 211–227. 10.1016/s0378-8741(02)00319-7
7
AgomuohA. A.AtaA.UdenigweC. C.AlukoR. E.IrenusI. (2013). Novel indole alkaloids from Nauclea latifolia and their renin-inhibitory activities. Chem. Biodivers.10, 401–410. 10.1002/cbdv.201200023
8
AhmadA.Van VuurenS.ViljoenA. (2014a). Unravelling the complex antimicrobial interactions of essential oils—the case of Thymus vulgaris (thyme). Molecules19, 2896–2910. 10.3390/molecules19032896
9
AhmadM.SultanaS.Fazl-I-HadiS.Ben HaddaT.RashidS.ZafarM.et al (2014b). An ethnobotanical study of medicinal plants in high mountainous region of Chail valley (District Swat- Pakistan). J. Ethnobiol. Ethnomed.10, 36. 10.1186/1746-4269-10-36
10
AjileyeO. O.ObuotorE. M.AkinkunmiE. O.AderogbaM. A. (2015). Isolation and characterization of antioxidant and antimicrobial compounds from Anacardium occidentale L. (Anacardiaceae) leaf extract. J. King Saud Univ. Sci.27, 244–252. 10.1016/j.jksus.2014.12.004
11
Aleksic SaboV.KnezevicP. (2019). Antimicrobial activity of Eucalyptus camaldulensis Dehn. plant extracts and essential oils: a review. Ind. Crop. Prod.132, 413–429. 10.1016/j.indcrop.2019.02.051
12
Ali-ShtayehM. S.YanivZ.MahajnaJ. (2000). Ethnobotanical survey in the Palestinian area: a classification of the healing potential of medicinal plants. J. Ethnopharmacol.73, 221–232. 10.1016/s0378-8741(00)00316-0
13
AliakbarluJ.ShameliF. (2013). In vitro antioxidant and antibacterial properties and total phenolic contents of essential oils from Thymus vulgaris, T. kotschyanus, Ziziphora tenuior and Z. clinopodioides. Turk. J. Biochem.38, 425–431. 10.5505/tjb.2013.58070
14
AmeyaG.GureA.DessalegnE. (2016). Antimicrobial activity of Echinops kebericho against human pathogenic bacteria and fungi. Ajtcam13, 199–203. 10.21010/ajtcam.v13i6.29
15
AminimoghadamfaroujN.NematollahiA.WiartC. (2011). Annonaceae: bio-resource for tomorrow’s drug discovery. J. Asian Nat. Prod. Res.13, 465–476. 10.1080/10286020.2011.570265
16
Andrade-CettoA. (2009). Ethnobotanical study of the medicinal plants from Tlanchinol, Hidalgo, México. J. Ethnopharmacol.122, 163–171. 10.1016/j.jep.2008.12.008
17
AndrewsJ. M. (2001). Determination of minimum inhibitory concentrations. J. Antimicrob. Chemother.48, 5–16. 10.1093/jac/48.suppl_1.5
18
APGChaseM. W.ChristenhuszM. J. M.FayM. F.ByngJ. W.JuddW. S.et al (2016). An update of the angiosperm phylogeny group classification for the orders and families of flowering plants: APG IV. Bot. J. Linn. Soc.181, 1–20. 10.1111/j.1095-8339.2009.00996.x
19
ArimaH.DannoG.-i. (2002). Isolation of antimicrobial compounds from guava (Psidium guajava L.) and their structural elucidation. Biosc. Biotech. Biochem.66, 1727–1730. 10.1271/bbb.66.1727
20
ArnoldH.-J.GulumianM. (1984). Pharmacopoeia of traditional medicine in Venda. J. Ethnopharmacol.12, 35–74. 10.1016/0378-8741(84)90086-2
21
AroA. O.DzoyemJ. P.AwouafackM. D.SelepeM. A.EloffJ. N.McgawL. J. (2019). Fractions and isolated compounds from Oxyanthus speciosus subsp. stenocarpus (Rubiaceae) have promising antimycobacterial and intracellular activity. BMC Complement. Med. Ther.19, 108. 10.1186/s12906-019-2520-x
22
AroA. O.DzoyemJ. P.EloffJ. N.McgawL. J. (2016). Extracts of six Rubiaceae species combined with rifampicin have good in vitro synergistic antimycobacterial activity and good anti-inflammatory and antioxidant activities. BMC Compl. Alternative Med.16, 385. 10.1186/s12906-016-1355-y
23
AroA. O.DzoyemJ. P.HlokweT. M.MadorobaE.EloffJ. N.McgawL. J. (2015). Some South African Rubiaceae tree leaf extracts have antimycobacterial activity against pathogenic and non-pathogenic Mycobacterium species. Phytother Res.29, 1004–1010. 10.1002/ptr.5338
24
BaiS.BhartiP.SeasotiyaL.MalikA.DalalS. (2015). In vitro screening and evaluation of some Indian medicinal plants for their potential to inhibit Jack bean and bacterial ureases causing urinary infections. Pharmaceut. Biol.53, 326–333. 10.3109/13880209.2014.918158
25
BakkaliF.AverbeckS.AverbeckD.IdaomarM. (2008). Biological effects of essential oils—a review. Food Chem. Toxicol.46, 446–475. 10.1016/j.fct.2007.09.106
26
BardajíD. K. R.Da SilvaJ. J. M.BianchiT. C.de Souza EugênioD.De OliveiraP. F.LeandroL. F.et al (2016). Copaifera reticulata oleoresin: chemical characterization and antibacterial properties against oral pathogens. Anaerobe40, 18–27. 10.1016/j.anaerobe.2016.04.017
27
BardaweelS. K.TawahaK. A.HudaibM. M. (2014). Antioxidant, antimicrobial and antiproliferative activities of Anthemis palestina essential oil. BMC Compl. Alternative Med.14, 297. 10.1186/1472-6882-14-297
28
BassettiM.MerelliM.TemperoniC.AstileanA. (2013). New antibiotics for bad bugs: where are we?. Ann. Clin. Microbiol. Antimicrob.12, 22. 10.1186/1476-0711-12-22
29
BecerrilR.NerínC.Gómez-LusR. (2012). Evaluation of bacterial resistance to essential oils and antibiotics after exposure to oregano and cinnamon essential oils. Foodborne Pathogens and Disease9, 699–705. 10.1089/fpd.2011.1097
30
BekaloT. H.WoodmatasS. D.WoldemariamZ. A. (2009). An ethnobotanical study of medicinal plants used by local people in the lowlands of Konta special woreda, southern Nations, nationalities and peoples regional state, Ethiopia. J. Ethnobiol. Ethnomed.5, 26. 10.1186/1746-4269-5-26
31
BelcherM. S.MahinthakumarJ.KeaslingJ. D. (2020). New frontiers: harnessing pivotal advances in microbial engineering for the biosynthesis of plant-derived terpenoids. Curr. Opin. Biotechnol.65, 88–93. 10.1016/j.copbio.2020.02.001
32
BerendsenR. L.PieterseC. M. J.BakkerP. A. H. M. (2012). The rhizosphere microbiome and plant health. Trends Plant Sci.17, 478–486. 10.1016/j.tplants.2012.04.001
33
BersanS. M. F.GalvãoL. C. C.GoesV. F. F.SartorattoA.FigueiraG. M.RehderV. L. G.et al (2014). Action of essential oils from Brazilian native and exotic medicinal species on oral biofilms. BMC Compl. Alternative Med.14, 451. 10.1186/1472-6882-14-451
34
Bisi-JohnsonM. A.ObiC. L.SamuelB. B.EloffJ. N.OkohA. I. (2017). Antibacterial activity of crude extracts of some South African medicinal plants against multidrug resistant etiological agents of diarrhoea. BMC Compl. Alternative Med.17, 321. 10.1186/s12906-017-1802-4
35
BogavacM.KaramanM.JanjuševićL.SudjiJ.RadovanovićB.NovakovićZ.et al (2015). Alternative treatment of vaginal infections—in vitro antimicrobial and toxic effects of Coriandrum sativum L. and Thymus vulgaris L. essential oils. J. Appl. Microbiol.119, 697–710. 10.1111/jam.12883
36
Boulekbache-MakhloufL.SlimaniS.MadaniK. (2013). Total phenolic content, antioxidant and antibacterial activities of fruits of Eucalyptus globulus cultivated in Algeria. Ind. Crop. Prod.41, 85–89. 10.1016/j.indcrop.2012.04.019
37
BozinB.Mimica-DukicN.SamojlikI.JovinE. (2007). Antimicrobial and antioxidant properties of rosemary and sage (Rosmarinus officinalis L. and Salvia officinalis L., Lamiaceae) essential oils. J. Agric. Food Chem.55, 7879–7885. 10.1021/jf0715323
38
BozinB.Mimica-DukicN.SiminN.AnackovG. (2006). Characterization of the volatile composition of essential oils of some Lamiaceae spices and the antimicrobial and antioxidant activities of the entire oils. J. Agric. Food Chem.54, 1822–1828. 10.1021/jf051922u
39
BozorgiM.MemarianiZ.MobliM.Salehi SurmaghiM. H.Shams-ArdekaniM. R.RahimiR. (2013). Five Pistacia species (P. vera, P. atlantica, P. terebinthus, P. khinjuk, and P. lentiscus): a review of their traditional uses, phytochemistry, and pharmacology. The Scientific World2013, 219815. 10.1155/2013/219815
40
BryanC. P. (1930). The papyrus Ebers. London: Geoffrey Bles.
41
BurtS. (2004). Essential oils: their antibacterial properties and potential applications in foods-a review. Int. J. Food Microbiol.94, 223–253. 10.1016/j.ijfoodmicro.2004.03.022
42
CaesarL. K.CechN. B. (2019). Synergy and antagonism in natural product extracts: when 1 + 1 does not equal 2. Nat. Prod. Rep.36, 869–888. 10.1039/c9np00011a
43
CakilciogluU.TurkogluI. (2010). An ethnobotanical survey of medicinal plants in Sivrice (Elazığ-Turkey). J. Ethnopharmacol.132, 165–175. 10.1016/j.jep.2010.08.017
44
Camejo-RodriguesJ.AscensãoL.BonetM. À.VallèsJ. (2003). An ethnobotanical study of medicinal and aromatic plants in the Natural Park of “Serra de São Mamede” (Portugal). J. Ethnopharmacol.89, 199–209. 10.1016/s0378-8741(03)00270-8
45
CDC (2019). Antibiotic resistance threats in the United States, 2019. Atlanta, GA: U.S. Department of Health and Human Services.
46
CeliktasO. Y.KocabasE. E. H.BedirE.SukanF. V.OzekT.BaserK. H. C. (2007). Antimicrobial activities of methanol extracts and essential oils of Rosmarinus officinalis, depending on location and seasonal variations. Food Chem.100, 553–559. 10.1016/j.foodchem.2005.10.011
47
ChaftarN.GirardotM.QuellardN.LabanowskiJ.GhrairiT.HaniK.et al (2015). Activity of six essential oils extracted from Tunisian plants against Legionella pneumophila. Chem. Biodivers.12, 1565–1574. 10.1002/cbdv.201400343
48
ChaiebK.HajlaouiH.ZmantarT.Kahla-NakbiA. B.RouabhiaM.MahdouaniK.et al (2007). The chemical composition and biological activity of clove essential oil, Eugenia caryophyllata (Syzigium aromaticum L. Myrtaceae): a short review. Phytother Res.21, 501–506. 10.1002/ptr.2124
49
ChakotiyaA. S.ChawlaR.ThakurP.TanwarA.NarulaA.GroverS. S.et al (2016). In vitro bactericidal activity of promising nutraceuticals for targeting multidrug resistant Pseudomonas aeruginosa. Nutrition32, 890–897. 10.1016/j.nut.2016.01.024
50
ChassagneF.CabanacG.HubertG.DavidB.MartiG. (2019). The landscape of natural product diversity and their pharmacological relevance from a focus on the Dictionary of Natural Products. Phytochemistry Rev.18, 601–622. 10.1007/s11101-019-09606-2
51
ChirayathR. B.Aparna ViswanathanA.JayakumarR.BiswasR.VijayachandranL. S. (2019). Development of Mangifera indica leaf extract incorporated carbopol hydrogel and its antibacterial efficacy against Staphylococcus aureus. Colloids Surf. B Biointerfaces178, 377–384. 10.1016/j.colsurfb.2019.03.034
52
ChotchoungchatchaiS.SaralampP.JenjittikulT.PornsiripongseS.PrathanturarugS. (2012). Medicinal plants used with Thai traditional medicine in modern healthcare Services: a case study in Kabchoeng hospital, Surin province, Thailand. J. Ethnopharmacol.141, 193–205. 10.1016/j.jep.2012.02.019
53
ChristenhuszM.ByngJ. (2016). The number of known plant species in the world and its annual increase. Phytotaxa261, 21–217. 10.11646/phytotaxa.261.3.1
54
ClarkeJ. T.WarnockR. C. M.DonoghueP. C. J. (2011). Establishing a time-scale for plant evolution. New Phytol.192, 266–301. 10.1111/j.1469-8137.2011.03794.x
55
CLSI (2012). Methods for dilution antimicrobial susceptibiity tests for bacteria that grow aerobically; approved standard; CLSI document M07-A9. Wayne, PA: Clinical and Laboratory Standards Institute.
56
CosP.VlietinckA. J.BergheD. V.MaesL. (2006). Anti-infective potential of natural products: how to develop a stronger in vitro 'proof-of-concept'. J. Ethnopharmacol.106, 290–302. 10.1016/j.jep.2006.04.003
57
CosentinoS.TuberosoC. I. G.PisanoB.SattaM.MasciaV.ArzediE.et al (1999). In-vitro antimicrobial activity and chemical composition of Sardinian Thymus essential oils. Lett. Appl. Microbiol.29, 130–135. 10.1046/j.1472-765x.1999.00605.x
58
CourtoisE. A.DexterK. G.PaineC. E. T.StienD.EngelJ.BaralotoC.et al (2016). Evolutionary patterns of volatile terpene emissions across 202 tropical tree species. Ecol. Evol.6, 2854–2864. 10.1002/ece3.1810
59
CraggG. M.NewmanD. J. (2005). Biodiversity: a continuing source of novel drug leads. Pure Appl. Chem.77, 7–24. 10.1351/pac200577010007
60
CulhamA.GornallR. J. (1994). The taxonomic significance of naphthoquinones in the Droseraceae. Biochem. Systemat. Ecol.22, 507–515. 10.1016/0305-1978(94)90045-0
61
Curcino VieiraI. J.Braz-FilhoR. (2006). “Quassinoids: structural diversity, biological activity and synthetic studies,” in Studies in natural products chemistry. Editor Atta UrR. (Amsterdam, Netherlands: Elsevier), 433–492. 10.1016/s1572-5995(06)80032-3
62
CvetanovićA.ZekovićZ.ZenginG.MaškovićP.PetronijevićM.RadojkovićM. (2019). Multidirectional approaches on autofermented chamomile ligulate flowers: antioxidant, antimicrobial, cytotoxic and enzyme inhibitory effects. South Afr. J. Bot.120, 112–118. 10.1016/j.sajb.2018.01.003
63
Da TrindadeR.Da SilvaJ.SetzerW. (2018). Copaifera of the neotropics: a review of the phytochemistry and pharmacology. IJMS19, 1511. 10.3390/ijms19051511
64
de AraújoJ. S. C.De CastilhoA. R. F.LiraA. B.PereiraA. V.de AzevêdoT. K. B.De Brito CostaE. M. d. M.et al (2018). Antibacterial activity against cariogenic bacteria and cytotoxic and genotoxic potential of Anacardium occidentale L. and Anadenanthera macrocarpa (Benth.) brenan extracts. Arch. Oral Biol.85, 113–119. 10.1016/j.archoralbio.2017.10.008
65
DellaA.Paraskeva-HadjichambiD.HadjichambisA. C. (2006). An ethnobotanical survey of wild edible plants of Paphos and Larnaca countryside of Cyprus. J. Ethnobiol. Ethnomed.2, 34. 10.1186/1746-4269-2-34
66
DettweilerM.MelanderR. J.PorrasG.RisenerC.MarquezL.SamarakoonT.et al (2020). A clerodane diterpene from Callicarpa americana resensitizes methicillin-resistant Staphylococcus aureus to β-lactam antibiotics. ACS Infect. Dis.6, 1667–1673. 10.1021/acsinfecdis.0c00307
67
DikeI. P.ObembeO. O.AdebiyiF. E. (2012). Ethnobotanical survey for potential anti-malarial plants in South-western Nigeria. J. Ethnopharmacol.144, 618–626. 10.1016/j.jep.2012.10.002
68
DlaminiN. P.SolomonS. (2019). Optimization of blending ratios of jam from Swazi indigenous fruits tincozi (Syzygium cordatum), tineyi (Phyllogeiton zeyheri) and umfomfo (Cephalanthus natalensis oliv.) using mixture design. Cogent. Food Agric.5, 1684864. 10.1080/23311932.2019.1684864
69
DoQ. D.AngkawijayaA. E.Tran-NguyenP. L.HuynhL. H.SoetaredjoF. E.IsmadjiS.et al (2014). Effect of extraction solvent on total phenol content, total flavonoid content, and antioxidant activity of Limnophila aromatica. J. Food Drug Anal.22, 296–302. 10.1016/j.jfda.2013.11.001
70
DoblerS.PetschenkaG.PankokeH. (2011). Coping with toxic plant compounds—the insect’s perspective on iridoid glycosides and cardenolides. Phytochemistry72, 1593–1604. 10.1016/j.phytochem.2011.04.015
71
DolatkhahiM.DolatkhahiA.NejadJ. B. (2014). Ethnobotanical study of medicinal plants used in Arjan—Parishan protected area in Fars Province of Iran. Avicenna J. Phytomed.4, 402–412.
72
DonatoR.SantomauroF.BiliaA. R.FlaminiG.SaccoC. (2015). Antibacterial activity of tuscan Artemisia annua essential oil and its major components against some foodborne pathogens. LWT—Food Sci. Technol. (Lebensmittel-Wissenschaft -Technol.)64, 1251–1254. 10.1016/j.lwt.2015.07.014
73
DrusanoG. L.PrestonS. L.FowlerC.CorradoM.WeisingerB.KahnJ. (2004). Relationship between fluoroquinolone area under the curve:minimum inhibitory concentration ratio and the probability of eradication of the infecting pathogen, in patients with nosocomial pneumonia. J. Infect. Dis.189, 1590–1597. 10.1086/383320
74
DzotamJ. K.KueteV. (2017). Antibacterial and antibiotic-modifying activity of methanol extracts from six Cameroonian food plants against multidrug-resistant enteric bacteria. BioMed Res. Int.2017, 1–19. 10.1155/2017/1583510
75
EdiriweeraM. K.TennekoonK. H.SamarakoonS. R. (2017). A review on ethnopharmacological applications, pharmacological activities, and bioactive compounds of Mangifera indica (mango). Evid. Based Complement. Alternat. Med.2017, 1–24. 10.1155/2017/6949835
76
EloffJ. (1998). A sensitive and quick microplate method to determine the minimal inhibitory concentration of plant extracts for bacteria. Planta Med.64, 711–713. 10.1055/s-2006-957563
77
EloffJ. N. (2004). Quantification the bioactivity of plant extracts during screening and bioassay guided fractionation. Phytomedicine11, 370–371. 10.1078/0944711041495218
78
EMA (2013). Assessment report on Eucalyptus globulus Labill., Eucalyptus polybractea R.T. Baker and/or Eucalyptus smithii R.T. Baker, aetheroleum. https://www.ema.europa.eu/en/documents/herbal-report/draft-assessment-report-eucalyptus-globulus-labill-e-polybractea-rt-baker-e-smithii-rt-baker_en (Accessed March 28, 2020).
79
EngW.NormanR. (2010). Development of an oregano-based ointment with anti-microbial activity including activity against methicillin-resistant Staphylococcus aureus. J. Drugs Dermatol. JDD9, 377–380.
80
EngelsC.SchieberA.GänzleM. G. (2011). Inhibitory spectra and modes of antimicrobial action of gallotannins from mango kernels (Mangifera indica L.). Appl. Environ. Microbiol.77, 2215. 10.1128/aem.02521-10
81
ErdemS. A.NabaviS. F.OrhanI. E.DagliaM.IzadiM.NabaviS. M. (2015). Blessings in disguise: a review of phytochemical composition and antimicrobial activity of plants belonging to the genus Eryngium. Daru23, 53. 10.1186/s40199-015-0136-3
82
FaboroE. O.WichitnithadW.FadareO. A.AkinpeluD. A.ObafemiC. A. (2016). Antibacterial and antioxidant activities and phytochemical screening of aqueous methanol extracts of eight Nigerian medicinal and aromatic plants. J. Pharm. Res.10, 523–532.
83
FanW.FanL.PengC.ZhangQ.WangL.LiL.et al (2019). Traditional uses, botany, phytochemistry, pharmacology, pharmacokinetics and toxicology of Xanthium strumarium L.: a review. Molecules24, 359. 10.3390/molecules24020359
84
FaniM.KohantebJ. (2017). In vitro antimicrobial activity of Thymus vulgaris essential oil against major oral pathogens. J. Evid. Based Complementary Altern. Med.22, 660–666. 10.1177/2156587217700772
85
FDA (2016). Botanical drug development guidance for industry. Fed. Regist.81, 96018–96020.
86
FernándezY. A.DamascenoJ. L.AbrãoF.SilvaT. d. S.CândidoA. d. L. P.FregoneziN. F.et al (2018). Antibacterial, preservative, and mutagenic potential of Copaifera spp. oleoresins against causative agents of foodborne diseases. Foodborne Pathog. Dis.15, 790–797. 10.1089/fpd.2018.2478
87
FournomitiM.KimbarisA.MantzouraniI.PlessasS.TheodoridouI.PapaemmanouilV.et al (2015). Antimicrobial activity of essential oils of cultivated oregano (Origanum vulgare), sage (Salvia officinalis), and thyme (Thymus vulgaris) against clinical isolates of Escherichia coli, Klebsiella oxytoca, and Klebsiella pneumoniae. Microb. Ecol. Health Dis.26, 23289. 10.3402/mehd.v26.23289
88
FranceschiV. R.NakataP. A. (2005). Calcium oxalate in plants: formation and function. Annu. Rev. Plant Biol.56, 41–71. 10.1146/annurev.arplant.56.032604.144106
89
FreiB.BaltisbergerM.SticherO.HeinrichM. (1998). Medical ethnobotany of the Zapotecs of the Isthmus‐Sierra (Oaxaca, Mexico): documentation and assessment of indigenous uses. J. Ethnopharmacol.62, 149–165. 10.1016/s0378-8741(98)00051-8
90
GastauerM.Meira NetoJ. A. A. (2017). Updated angiosperm family tree for analyzing phylogenetic diversity and community structure. Acta Bot. Bras.31, 191–198. 10.1590/0102-33062016abb0306
91
GemechuA.GidayM.WorkuA.AmeniG. (2013). In vitro anti-mycobacterial activity of selected medicinal plants against Mycobacterium tuberculosis and Mycobacterium bovis strains. BMC Compl. Alternative Med.13, 291. 10.1186/1472-6882-13-291
92
GhasemianA.EslamiM.HasanvandF.BozorgiH.Al-AbodiH. R. (2019). Eucalyptus camaldulensis properties for use in the eradication of infections. Comp. Immunol. Microbiol. Infect. Dis.65, 234–237. 10.1016/j.cimid.2019.04.007
93
GhorbaniA.EsmaeilizadehM. (2017). Pharmacological properties of Salvia officinalis and its components. J. Tradit. Complement. Med.7, 433–440. 10.1016/j.jtcme.2016.12.014
94
GhrairiT.HaniK. (2015). Enhanced bactericidal effect of enterocin A in combination with thyme essential oils against L. monocytogenes and E. coli O157:H7. J. Food Sci. Technol.52, 2148–2156. 10.1007/s13197-013-1214-5
95
GibbonsS. (2004). Anti-staphylococcal plant natural products. Nat. Prod. Rep.21, 263–277. 10.1039/b212695h
96
GilbertB.AlvesL. (2003). Synergy in plant medicines. CMC10, 13–20. 10.2174/0929867033368583
97
GolestaniM. R.RadM.BassamiM.Afkhami-GoliA. (2015). Analysis and evaluation of antibacterial effects of new herbal formulas, AP-001 and AP-002, against Escherichia coli O157:H7. Life Sci.135, 22–26. 10.1016/j.lfs.2015.05.007
98
GomesC. B.CavalcanteD.FilhoJ. G.Da CostaF.Da Silva PereiraS. (2016). Clinical effect of a mouthwash containing Anacardium occidentale Linn. On plaque and gingivitis control: a randomized controlled trial. Indian J. Dent. Res.27, 364–369. 10.4103/0970-9290.191883
99
GuptaP.BirdiT. (2015). Psidium guajava leaf extract prevents intestinal colonization of Citrobacter rodentium in the mouse model. J. Ayurveda Integr. Med.6, 50–52. 10.4103/0975-9476.146557
100
GuptaV. K.FatimaA.FaridiU.NegiA. S.ShankerK.KumarJ. K.et al (2008). Antimicrobial potential of Glycyrrhiza glabra roots. J. Ethnopharmacol.116, 377–380. 10.1016/j.jep.2007.11.037
101
GurungP.DeP. (2017). Spectrum of biological properties of Cinchona alkaloids: a brief review. J. Pharmacogn. Phytochem.6, 162–166.
102
GutiérrezR. M. P.MitchellS.SolisR. V. (2008). Psidium guajava: a review of its traditional uses, phytochemistry and pharmacology. J. Ethnopharmacol.117, 1–27. 10.1016/j.jep.2008.01.025
103
GüzelY.GüzelşemmeM.MiskiM. (2015). Ethnobotany of medicinal plants used in Antakya: a multicultural district in Hatay Province of Turkey. J. Ethnopharmacol.174, 118–152. 10.1016/j.jep.2015.07.042
104
HajlaouiH.MighriH.AouniM.GharsallahN.KadriA. (2016). Chemical composition and in vitro evaluation of antioxidant, antimicrobial, cytotoxicity and anti-acetylcholinesterase properties of Tunisian Origanum majorana L. essential oil. Microb. Pathog.95, 86–94. 10.1016/j.micpath.2016.03.003
105
HayderN.Ben AmmarR.AbdelwahedA.KilaniS.MahmoudA.Ben ChibaniJ.et al (2005). Antibacterial and antimutagenic activitiy of extracts and essential oil from (Tunisian) Pistacia lentiscus. Toxicol. Environ. Chem.87, 567–573. 10.1080/02772240500399823
106
HelalI. M.El-BessoumyA.Al-BatainehE.JosephM. R. P.RajagopalanP.ChandramoorthyH. C.et al (2019). Antimicrobial efficiency of essential oils from traditional medicinal plants of asir region, Saudi Arabia, over drug resistant isolates. BioMed Res. Int.2019, 8928306. 10.1155/2019/8928306
107
HirudkarJ. R.ParmarK. M.PrasadR. S.SinhaS. K.LomteA. D.ItankarP. R.et al (2020). The antidiarrhoeal evaluation of Psidium guajava L. against enteropathogenic Escherichia coli induced infectious diarrhoea. J. Ethnopharmacol.251, 112561. 10.1016/j.jep.2020.112561
108
HossainM. A.KabirM. J.SalehuddinS. M.RahmanS. M. M.DasA. K.SinghaS. K.et al (2010). Antibacterial properties of essential oils and methanol extracts of sweet basil (Ocimum basilicum) occurring in Bangladesh. Pharmaceut. Biol.48, 504–511. 10.3109/13880200903190977
109
HussainA. I.AnwarF.Hussain SheraziS. T.PrzybylskiR. (2008). Chemical composition, antioxidant and antimicrobial activities of basil (Ocimum basilicum) essential oils depends on seasonal variations. Food Chem.108, 986–995. 10.1016/j.foodchem.2007.12.010
110
IbrahimS. R. M.MohamedG. A. (2015). Naphthylisoquinoline alkaloids potential drug leads. Fitoterapia106, 194–225. 10.1016/j.fitote.2015.09.014
111
InuiT.WangY.ProS. M.FranzblauS. G.PauliG. F. (2012). Unbiased evaluation of bioactive secondary metabolites in complex matrices. Fitoterapia83, 1218–1225. 10.1016/j.fitote.2012.06.012
112
IvkerR. S. (2018). “Chapter 17-chronic sinusitis,” in Integrative medicine. 4th Edn, Editor RakelD. (Amsterdam, Netherlands: Elsevier), 157–169.e152. 10.1016/b978-0-323-35868-2.00017-7
113
JaiswalY.LiangZ.ZhaoZ. (2016). Botanical drugs in ayurveda and traditional Chinese medicine. J. Ethnopharmacol.194, 245–259. 10.1016/j.jep.2016.06.052
114
JamilaF.MostafaE. (2014). Ethnobotanical survey of medicinal plants used by people in oriental Morocco to manage various ailments. J. Ethnopharmacol.154, 76–87. 10.1016/j.jep.2014.03.016
115
JardakM.Elloumi-MseddiJ.AifaS.MnifS. (2017). Chemical composition, anti-biofilm activity and potential cytotoxic effect on cancer cells of Rosmarinus officinalis L. essential oil from Tunisia. Lipids Health Dis.16, 190. 10.1186/s12944-017-0580-9
116
JiangM.ZhaoS.YangS.LinX.HeX.WeiX.et al (2020). An “essential herbal medicine”-licorice: a review of phytochemicals and its effects in combination preparations. J. Ethnopharmacol.249, 112439. 10.1016/j.jep.2019.112439
117
JonesW. P.KinghornA. D. (2005). Extraction of plant secondary metabolites. Natural Products Isolation, 323–351. 10.1385/1-59259-955-9:323
118
JordánM. J.LaxV.RotaM. C.LoránS.SotomayorJ. A. (2012). Relevance of carnosic acid, carnosol, and rosmarinic acid concentrations in the in vitro antioxidant and antimicrobial activities of Rosmarinus officinalis (L.) methanolic extracts. J. Agric. Food Chem.60, 9603–9608. 10.1021/jf302881t
119
KalembaD.KunickaA. (2003). Antibacterial and antifungal properties of essential oils. CMC10, 813–829. 10.2174/0929867033457719
120
KamatouG. P.VermaakI.ViljoenA. M. (2012). Eugenol-from the remote Maluku Islands to the international market place: a review of a remarkable and versatile molecule. Molecules17, 6953–6981. 10.3390/molecules17066953
121
KaramanoliK.Menkissoglu-SpiroudiU.BosabalidisA. M.VokouD.ConstantinidouH.-I. A. (2005). Bacterial colonization of the phyllosphere of nineteen plant species and antimicrobial activity of their leaf secondary metabolites against leaf associated bacteria. Chemoecology15, 59–67. 10.1007/s00049-005-0297-5
122
KayaniS.AhmadM.ZafarM.SultanaS.KhanM. P. Z.AshrafM. A.et al (2014). Ethnobotanical uses of medicinal plants for respiratory disorders among the inhabitants of Gallies - Abbottabad, Northern Pakistan. J. Ethnopharmacol.156, 47–60. 10.1016/j.jep.2014.08.005
123
KesslerA.KalskeA. (2018). Plant secondary metabolite diversity and species interactions. Annu. Rev. Ecol. Evol. Syst.49, 115–138. 10.1146/annurev-ecolsys-110617-062406
124
KimY.WyslouzilB. E.WeathersP. J. (2002). Secondary metabolism of hairy root cultures in bioreactors. In Vitro Cell. Dev. Biol.—Plant38, 1–10. 10.1079/ivp2001243
125
KnezevicP.AleksicV.SiminN.SvircevE.PetrovicA.Mimica-DukicN. (2016). Antimicrobial activity of Eucalyptus camaldulensis essential oils and their interactions with conventional antimicrobial agents against multi-drug resistant Acinetobacter baumannii. J. Ethnopharmacol.178, 125–136. 10.1016/j.jep.2015.12.008
126
KovácikJ.RepcákM. (2006). Naphthoquinones content of some sundews (Drosera L.).Carniv. Plant Newsl.35, 49–51.
127
KubitzkiK. (2013). “Chemosystematics,” in The Families and Genera of flowering plants. XII. Flowering plants: eudicots. Santalales, balanophorales, Editor KubitzkiK. (Berlin, Germany: Springer), 43–48.
128
KueteV. (2010). Potential of Cameroonian plants and derived products against microbial infections: a review. Planta Med.76, 1479–1491. 10.1055/s-0030-1250027
129
KurekciC.Bishop-HurleyS. L.VercoeP. E.DurmicZ.Al JassimR. A. M.McsweeneyC. S. (2012). Screening of Australian plants for antimicrobial activity against Campylobacter jejuni. Phytother Res.26, 186–190. 10.1002/ptr.3526
130
LaghaR.Ben AbdallahF.Al-SarhanB.Al-SodanyY. (2019). Antibacterial and biofilm inhibitory activity of medicinal plant essential oils against Escherichia coli isolated from UTI patients. Molecules24, 1161. 10.3390/molecules24061161
131
LahmarA.BedouiA.Mokdad-BzeouichI.DhaouifiZ.KalboussiZ.CheraifI.et al (2017). Reversal of resistance in bacteria underlies synergistic effect of essential oils with conventional antibiotics. Microb. Pathog.106, 50–59. 10.1016/j.micpath.2016.10.018
132
LandoulsiA.RoumyV.DuhalN.SkhiriF. H.RivièreC.SahpazS.et al (2016). Chemical composition and antimicrobial activity of the essential oil from aerial parts and roots of Eryngium barrelieri Boiss. and Eryngium glomeratum Lam. from Tunisia. Chem. Biodivers.13, 1720–1729. 10.1002/cbdv.201600136
133
LawalT. O.AdeniyiB. A.AdegokeA. O.FranzblauS. G.MahadyG. B. (2012). In vitrosusceptibility of Mycobacterium tuberculosisto extracts of Eucalyptus camaldulensis and Eucalyptus torelliana and isolated compounds. Pharmaceut. Biol.50, 92–98. 10.3109/13880209.2011.625953
134
LeeH.-K.SongH. E.LeeH.-B.KimC.-S.KoketsuM.Thi My NganL.et al (2014). Growth inhibitory, bactericidal, and morphostructural effects of dehydrocostus lactone from Magnolia sieboldii leaves on antibiotic-susceptible and -resistant strains of Helicobacter pylori. PLoS One9, e95530. 10.1371/journal.pone.0095530
135
LessaF. C. R.GrilloC. H. B.PintoF. E.LorençonB. B.MartinsJ. D. L.BertolucciS. K. V.et al (2012). Efficacy of guaco mouthwashes (Mikania glomerata and Mikania laevigata) on the disinfection of toothbrushes. Rev. Bras. Farmacogn.22, 1330–1337. 10.1590/s0102-695x2012005000115
136
LetunicI.BorkP. (2006). Interactive tree of life (iTOL): an online tool for phylogenetic tree display and annotation. Bioinformatics23, 127–128. 10.1093/bioinformatics/btl529
137
LiD.-L.XingF.-W. (2016). Ethnobotanical study on medicinal plants used by local Hoklos people on Hainan Island, China. J. Ethnopharmacol.194, 358–368. 10.1016/j.jep.2016.07.050
138
LimsuwanS.Hesseling-MeindersA.VoravuthikunchaiS. P.Van DijlJ. M.KayserO. (2011). Potential antibiotic and anti-infective effects of rhodomyrtone from Rhodomyrtus tomentosa (Aiton) Hassk. On Streptococcus pyogenes as revealed by proteomics. Phytomedicine18, 934–940. 10.1016/j.phymed.2011.02.007
139
LimsuwanS.MoosigapongK.JarukitsakulS.JoycharatN.ChusriS.JaisamutP.et al (2018). Lupinifolin from Albizia myriophylla wood: a study on its antibacterial mechanisms against cariogenic Streptococcus mutans. Arch. Oral Biol.93, 195–202. 10.1016/j.archoralbio.2017.10.013
140
LimsuwanS.VoravuthikunchaiS. P. (2013). Bactericidal, bacteriolytic, and antibacterial virulence activities of Boesenbergia pandurata (Roxb.) Schltr. extract against Streptococcus pyogenes. Trop. J. Pharm. Res.12, 1023–1028. 10.4314/tjpr.v12i4.14
141
LindemanZ.WaggonerM.BatdorffA.HumphreysT. L. (2014). Assessing the antibiotic potential of essential oils against Haemophilus ducreyi. BMC Complement. Altern. Med.14, 172. 10.1186/1472-6882-14-172
142
LiuH.-X.TanH.-B.QiuS.-X. (2016). Antimicrobial acylphloroglucinols from the leaves of Rhodomyrtus tomentosa. J. Asian Nat. Prod. Res.18, 535–541. 10.1080/10286020.2015.1121997
143
LocherC.CurrieL. (2010). Revisiting kinos-An Australian perspective. J. Ethnopharmacol.128, 259–267. 10.1016/j.jep.2010.01.028
144
LoiM. C.MaxiaL.MaxiaA. (2005). Ethnobotanical comparison between the villages of Escolca and Lotzorai (Sardinia, Italy). J. Herbs, Spices, Med. Plants11, 67–84. 10.1300/j044v11n03_07
145
LozoyaX.Reyes-MoralesH.Chávez-SotoM. A.Martı́nez-Garcı́aM. D. C.Soto-GonzálezY.DoubovaS. V.et al (2002). Intestinal anti-spasmodic effect of a phytodrug of Psidium guajava folia in the treatment of acute diarrheic disease. J. Ethnopharmacol.83, 19–24. 10.1016/s0378-8741(02)00185-x
146
LuM.DaiT.MurrayC. K.WuM. X. (2018). Bactericidal property of oregano oil against multidrug-resistant clinical isolates. Front. Microbiol.9. 10.3389/fmicb.2018.02329
147
LuísÂ.DuarteA.GominhoJ.DominguesF.DuarteA. P. (2016). Chemical composition, antioxidant, antibacterial and anti-quorum sensing activities of Eucalyptus globulus and Eucalyptus radiata essential oils. Ind. Crop. Prod.79, 274–282. 10.1016/j.indcrop.2015.10.055
148
MackovaZ.KoblovskaR.LapcikO. (2006). Distribution of isoflavonoids in non-leguminous taxa—an update. Phytochemistry67, 849–855. 10.1016/j.phytochem.2006.01.020
149
MadureiraA. M.RamalheteC.MulhovoS.DuarteA.FerreiraM.-J. U. (2012). Antibacterial activity of some African medicinal plants used traditionally against infectious diseases. Pharmaceut. Biol.50, 481–489. 10.3109/13880209.2011.615841
150
MagallónS. A.HiluK. W. (2009). “Land plants (embryophyta),” in The Timetree of life, Editors HedgesB.S.KumarS. (New York, NY: Oxford University Press), 133–137.
151
MagallonS.CraneP. R.HerendeenP. S. (1999). Phylogenetic pattern, diversity, and diversification of eudicots. Ann. Mo. Bot. Gard.86, 297–372. 10.2307/2666180
152
MahmoudzadehM.HosseiniH.NasrollahzadehJ.KhaneghahA. M.RismanchiM.ChavesR. D.et al (2016). Antibacterial activity of Carum copticum essential oil against Escherichia coli O157:H7 in meat: stx genes expression. Curr. Microbiol.73, 265–272. 10.1007/s00284-016-1048-2
153
MahyariS.MahyariB.EmamiS. A.Malaekeh-NikoueiB.JahanbakhshS. P.SahebkarA.et al (2016). Evaluation of the efficacy of a polyherbal mouthwash containing Zingiber officinale, Rosmarinus officinalis and Calendula officinalis extracts in patients with gingivitis: a randomized double-blind placebo-controlled trial. Compl. Ther. Clin. Pract.22, 93–98. 10.1016/j.ctcp.2015.12.001
154
MarinoM.BersaniC.ComiG. (2001). Impedance measurements to study the antimicrobial activity of essential oils from Lamiaceae and Compositae. Int. J. Food Microbiol.67, 187–195. 10.1016/s0168-1605(01)00447-0
155
MaroyiA. (2017). Acacia karroo Hayne: ethnomedicinal uses, phytochemistry and pharmacology of an important medicinal plant in southern Africa. Asian Pacific Journal of Tropical Medicine10, 351–360. 10.1016/j.apjtm.2017.03.021
156
MartinsM. D.MarquesM. M.BussadoriS. K.MartinsM. A. T.PavesiV. C. S.Mesquita-FerrariR. A.et al (2009). Comparative analysis between Chamomilla recutita and corticosteroids on wound healing. An in vitro and in vivo study. Phytother Res.23, 274–278. 10.1002/ptr.2612
157
MatejićJ. S.Stojanović-RadićZ. Z.RistićM. S.VeselinovićJ. B.ZlatkovićB. K.MarinP. D.et al (2018). Chemical characterization, in vitro biological activity of essential oils and extracts of three Eryngium L. species and molecular docking of selected major compounds. J. Food Sci. Technol.55, 2910–2925. 10.1007/s13197-018-3209-8
158
MawalagederaS. M. U. P.CallahanD. L.GaskettA. C.RønstedN.SymondsM. R. E. (2019). Combining evolutionary inference and metabolomics to identify plants with medicinal potential. Front. Ecol. Evol.7. 10.3389/fevo.2019.00267
159
MazokopakisE. E.VrentzosG. E.PapadakisJ. A.BabalisD. E.GanotakisE. S. (2005). Wild chamomile (Matricaria recutita L.) mouthwashes in methotrexate-induced oral mucositis. Phytomedicine12, 25–27. 10.1016/j.phymed.2003.11.003
160
McewenS. A.CollignonP. J. (2018). Antimicrobial resistance: a one health perspective. Microbiol. Spectr.6. 10.1128/microbiolspec.ARBA-0009-2017
161
McKayD. L.BlumbergJ. B. (2006). A review of the bioactivity and potential health benefits of peppermint tea (Mentha piperita L.). Phytother Res.20, 619–633. 10.1002/ptr.1936
162
Metrouh-AmirH.DuarteC. M. M.MaizaF. (2015). Solvent effect on total phenolic contents, antioxidant, and antibacterial activities of Matricaria pubescens. Ind. Crop. Prod.67, 249–256. 10.1016/j.indcrop.2015.01.049
163
MNPS (2020). Medicinal plant names services (MNPS). Available at: https://mpns.science.kew.org/mpns-portal/.
164
ModarresiM.FarahpourM.-R.BaradaranB. (2019). Topical application of Mentha piperita essential oil accelerates wound healing in infected mice model. Inflammopharmacology27, 531–537. 10.1007/s10787-018-0510-0
165
MoherD.LiberatiA.TetzlaffJ.AltmanD. G.TheP. G. (2009). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med.6, e1000097. 10.1371/journal.pmed.1000097
166
Moosavi-NasabM.Jamal SaharkhizM.ZiaeeE.MoayediF.KoshaniR.AziziR. (2016). Chemical compositions and antibacterial activities of five selected aromatic plants essential oils against food-borne pathogens and spoilage bacteria. J. Essent. Oil Res.28, 241–251. 10.1080/10412905.2015.1119762
167
MordmuangA.BrouilletteE.VoravuthikunchaiS. P.MalouinF. (2019). Evaluation of a Rhodomyrtus tomentosa ethanolic extract for its therapeutic potential on Staphylococcus aureus infections using in vitro and in vivo models of mastitis. Vet. Res.50, 49. 10.1186/s13567-019-0664-9
168
MoreiraM. R.SouzaA. B.SoaresS.BianchiT. C.de Souza EugênioD.LemesD. C.et al (2016). Ent-kaurenoic acid-rich extract from Mikania glomerata: in vitro activity against bacteria responsible for dental caries. Fitoterapia112, 211–216. 10.1016/j.fitote.2016.06.007
169
MoretiD. L. C.LeandroL. F.Da Silva MoraesT.MoreiraM. R.Sola VenezianiR. C.AmbrosioS. R.et al (2017). Mikania glomerata Sprengel extract and its major compound ent -kaurenoic acid display activity against bacteria present in endodontic infections. Anaerobe47, 201–208. 10.1016/j.anaerobe.2017.06.008
170
Morvin YabeshJ. E.PrabhuS.VijayakumarS. (2014). An ethnobotanical study of medicinal plants used by traditional healers in Silent Valley of Kerala, India. J. Ethnopharmacol.154, 774–789. 10.1016/j.jep.2014.05.004
171
MuhsA.LylesJ. T.ParletC. P.NelsonK.KavanaughJ. S.HorswillA. R.et al (2017). Virulence inhibitors from Brazilian peppertree block quorum sensing and abate dermonecrosis in skin infection models. Sci. Rep.7, 42275. 10.1038/srep42275
172
MyersN.MittermeierR. A.MittermeierC. G.Da FonsecaG. A. B.KentJ. (2000). Biodiversity hotspots for conservation priorities. Nature403, 853–858. 10.1038/35002501
173
Na-PhatthalungP.ChusriS.SuanyukN.VoravuthikunchaiS. P. (2017). In vitro and in vivo assessments of Rhodomyrtus tomentosa leaf extract as an alternative anti-streptococcal agent in nile tilapia (Oreochromis niloticus L.). J. Med. Microbiol.66, 430–439. 10.1099/jmm.0.000453
174
NaberK. (2013). Efficacy and safety of the phytotherapeutic drug Canephron® N in prevention and treatment of urogenital and gestational disease: review of clinical experience in Eastern Europe and Central Asia. Res. Rep. Urol.5, 39–46. 10.2147/rru.s39288
175
NapimogaM. H.YatsudaR. (2010). Scientific evidence for Mikania laevigata and Mikania glomerata as a pharmacological tool. J. Pharm. Pharmacol.62, 809–820. 10.1211/jpp.62.07.0001
176
NasirM.TafessK.AbateD. (2015). Antimicrobial potential of the Ethiopian Thymus schimperi essential oil in comparison with others against certain fungal and bacterial species. BMC Compl. Alternative Med.15, 260. 10.1186/s12906-015-0784-3
177
NcikiS.VuurenS.Van EykA.De WetH. (2016). Plants used to treat skin diseases in northern Maputaland, South Africa: antimicrobial activity and in vitro permeability studies. Pharmaceut. Biol.54, 2420–2436. 10.3109/13880209.2016.1158287
178
NejadA. S. M.KamkarA.GiriA.PourmahmoudiA. A. (2013). Ethnobotany and folk medicinal uses of major trees and shrubs in Northern Iran. J. Med. Plants Res.7, 284–289. 10.5897/JMPR11.680
179
NielsenT. R. H.KueteV.JägerA. K.MeyerJ. J. M.LallN. (2012). Antimicrobial activity of selected South African medicinal plants. BMC Compl. Alternative Med.12, 74. 10.1186/1472-6882-12-74
180
NLM (2020). National library of medicine (US). Available from: http://clinicaltrials.gov (Cited March 31, 2020).
181
NyilaM. A.LeonardC. M.HusseinA. A.LallN. (2012). Activity of South African medicinal plants against Listeria monocytogenes biofilms, and isolation of active compounds from Acacia karroo. South Afr. J. Bot.78, 220–227. 10.1016/j.sajb.2011.09.001
182
O'NeillJ. (2016). Tackling drug-resistant infections globally: final report and recommendations: Review on Antimicrobial Resistance.
183
OdedinaG.VongkamjanK.VoravuthikunchaiS. (2015). Potential bio-control agent from Rhodomyrtus tomentosa against Listeria monocytogenes. Nutrients7, 7451–7468. 10.3390/nu7095346
184
OdonneG.ValadeauC.Alban-CastilloJ.StienD.SauvainM.BourdyG. (2013). Medical ethnobotany of the Chayahuita of the Paranapura basin (Peruvian amazon). J. Ethnopharmacol.146, 127–153. 10.1016/j.jep.2012.12.014
185
OngH. C.NordianaM. (1999). Malay ethno-medico botany in Machang, Kelantan, Malaysia. Fitoterapia70, 502–513. 10.1016/s0367-326x(99)00077-5
186
OuelbaniR.BensariS.MouasT. N.KhelifiD. (2016). Ethnobotanical investigations on plants used in folk medicine in the regions of Constantine and Mila (North-East of Algeria). J. Ethnopharmacol.194, 196–218. 10.1016/j.jep.2016.08.016
187
OzdikmenliS.Demirel ZorbaN. N. (2015). Evaluation of usage of essential oils instead of spices in meat ball formulation for controlling Salmonella spp. Food Sci. Technol. Int.22, 93–101. 10.1177/1082013215571118
188
PandaS. K.Da SilvaL. C. N.SahalD.LeontiM. (2019). Editorial: ethnopharmacological studies for the development of drugs with special reference to Asteraceae. Front. Pharmacol.10, 955. 10.1109/tencon.2019.8929608
189
ParaschosS.MagiatisP.MitakouS.PetrakiK.KalliaropoulosA.MaragkoudakisP.et al (2007). In vitro and in vivo activities of chios mastic gum extracts and constituents against Helicobacter pylori. Antimicrob. Agents. Chemother.51, 551. 10.1128/aac.00642-06
190
PasterN.MenasherovM.RavidU.JuvenB. (1995). Antifungal activity of oregano and thyme essential oils applied as fumigants against fungi attacking stored grain. J. Food Protect.58, 81–85. 10.4315/0362-028x-58.1.81
191
PastorinoG.CornaraL.SoaresS.RodriguesF.OliveiraM. B. P. P. (2018). Liquorice (Glycyrrhiza glabra): a phytochemical and pharmacological review. Phytother. Res.32, 2323–2339. 10.1002/ptr.6178
192
PetroliniF. V. B.LucariniR.de SouzaM. G. M.PiresR. H.CunhaW. R.MartinsC. H. G. (2013). Evaluation of the antibacterial potential of Petroselinum crispum and Rosmarinus officinalis against bacteria that cause urinary tract infections. Braz. J. Microbiol.44, 829–834. 10.1590/s1517-83822013005000061
193
PetronilhoS.MaraschinM.CoimbraM. A.RochaS. M. (2012). In vitro and in vivo studies of natural products: a challenge for their valuation. The case study of chamomile (Matricaria recutita L.). Ind. Crop. Prod.40, 1–12. 10.1016/j.indcrop.2012.02.041
194
Pfeifer BarbosaA. L.Wenzel-StorjohannA.BarbosaJ. D.ZidornC.PeiferC.TasdemirD.et al (2019). Antimicrobial and cytotoxic effects of the Copaifera reticulata oleoresin and its main diterpene acids. J. Ethnopharmacol.233, 94–100. 10.1016/j.jep.2018.11.029
195
PhoemA. N.VoravuthikunchaiS. P. (2012). Growth stimulation/inhibition effect of medicinal plants on human intestinal microbiota. Food Sci. Biotechnol.21, 739–745. 10.1007/s10068-012-0096-z
196
PlowdenC. (2004). The ethnobotany of Copaíba (Copaifera) oleoresin in the Amazon. Econ. Bot.58, 729–733. 10.1663/0013-0001(2004)058[0729:teocco]2.0.co;2
197
PolatR.SatilF. (2012). An ethnobotanical survey of medicinal plants in Edremit Gulf (Balıkesir—Turkey). J. Ethnopharmacol.139, 626–641. 10.1016/j.jep.2011.12.004
198
PorrasG.ChassagneF.LylesJ. T.MarquezL.DettweilerM.SalamA. M.et al (2020). Ethnobotany and the role of plant natural products in antibiotic discovery. Chem. Rev.10.1021/acs.chemrev.0c00922
199
PulajB.MustafaB.NelsonK.QuaveC. L.HajdariA. (2016). Chemical composition and in vitro antibacterial activity of Pistacia terebinthus essential oils derived from wild populations in Kosovo. BMC Compl. Alternative Med.16, 147. 10.1186/s12906-016-1135-8
200
RashidS.RatherM. A.ShahW. A.BhatB. A. (2013). Chemical composition, antimicrobial, cytotoxic and antioxidant activities of the essential oil of Artemisia indica Willd. Food Chem.138, 693–700. 10.1016/j.foodchem.2012.10.102
201
RasooliI.ShayeghS.AstanehS. (2009). The effect of Mentha spicata and Eucalyptus camaldulensis essential oils on dental biofilm. Int. J. Dent. Hyg.7, 196–203. 10.1111/j.1601-5037.2009.00389.x
202
RezazadehF.MahdaviM.MotavalizadehkakhkyA.MehrzadJ.AbediF.Roozbeh-Nasira'eiL.et al (2014). Essential oil composition of three population of Tanacetum polycephalum from Iran and their antimicrobial activity. J. Essent. Oil-Bear. Plants17, 317–330. 10.1080/0972060x.2013.813260
203
RischerH.HammA.BringmannG. (2002). Nepenthes insignis uses a C2-portion of the carbon skeleton of l-alanine acquired via its carnivorous organs, to build up the allelochemical plumbagin. Phytochemistry59, 603–609. 10.1016/s0031-9422(02)00003-1
204
RiveraD.AllkinR.ObónC.AlcarazF.VerpoorteR.HeinrichM. (2014). What is in a name? The need for accurate scientific nomenclature for plants. J. Ethnopharmacol.152, 393–402. 10.1016/j.jep.2013.12.022
205
RomeroM. d. C.ValeroA.Martín-SánchezJ.Navarro-MollM. C. (2012). Activity of Matricaria chamomilla essential oil against anisakiasis. Phytomedicine19, 520–523. 10.1016/j.phymed.2012.02.005
206
RoomianiL.SoltaniM.Akhondzadeh BastiA.MahmoodiA.MirghaedT.YadollahiF. (2013). Evaluation of the chemical composition and in vitro antimicrobial activity of Rosmarinus officinalis, Zataria multiflora, Anethum graveolens and Eucalyptus globulus against Streptococcus iniae; the cause of zoonotic disease in farmed fish. Iran. J. Fish. Sci.12, 702–716.
207
Rosas-PiñónY.MejíaA.Díaz-RuizG.AguilarM. I.Sánchez-NietoS.Rivero-CruzJ. F. (2012). Ethnobotanical survey and antibacterial activity of plants used in the altiplane region of Mexico for the treatment of oral cavity infections. J. Ethnopharmacol.141, 860–865. 10.1016/j.jep.2012.03.020
208
RotaM. C.HerreraA.MartínezR. M.SotomayorJ. A.JordánM. J. (2008). Antimicrobial activity and chemical composition of Thymus vulgaris, Thymus zygis and Thymus hyemalis essential oils. Food Contr.19, 681–687. 10.1016/j.foodcont.2007.07.007
209
SalemM. Z. M.El-HefnyM.AliH. M.ElansaryH. O.NasserR. A.El-SettawyA. A. A.et al (2018). Antibacterial activity of extracted bioactive molecules of Schinus terebinthifolius ripened fruits against some pathogenic bacteria. Microb. Pathog.120, 119–127. 10.1016/j.micpath.2018.04.040
210
SanchesN. R.Garcia CortezD. A.SchiaviniM. S.NakamuraC. V.Dias FilhoB. P. (2005). An evaluation of antibacterial activities of Psidium guajava (L.). Braz. Arch. Biol. Technol.48, 429–436. 10.1590/s1516-89132005000300014
211
SantosM. I. S.MartinsS. R.VeríssimoC. S. C.NunesM. J. C.LimaA. I. G.FerreiraR. M. S. B.et al (2017). Essential oils as antibacterial agents against food-borne pathogens: are they really as useful as they are claimed to be?. J. Food Sci. Technol.54, 4344–4352. 10.1007/s13197-017-2905-0
212
SaralampP. (1996). Medicinal plants in Thailand. Bangkok, Thailand: Department of Pharmaceutical Botany.
213
SarkerS. D.NaharL.KumarasamyY. (2007). Microtitre plate-based antibacterial assay incorporating resazurin as an indicator of cell growth, and its application in the in vitro antibacterial screening of phytochemicals. Methods42, 321–324. 10.1016/j.ymeth.2007.01.006
214
ShakeriA.AkhtariJ.SoheiliV.TaghizadehS. F.SahebkarA.ShaddelR.et al (2017). Identification and biological activity of the volatile compounds of Glycyrrhiza triphylla Fisch. & C. A. Mey. Microb. Pathog.109, 39–44. 10.1016/j.micpath.2017.05.022
215
ShandukaniP. D.TshidinoS. C.MasokoP.MoganediK. M. (2018). Antibacterial activity and in situ efficacy of Bidens pilosa Linn and Dichrostachys cinerea Wight et Arn extracts against common diarrhoea-causing waterborne bacteria. BMC Compl. Alternative Med.18, 171. 10.1186/s12906-018-2230-9
216
Sharifi-RadJ.Hoseini-AlfatemiM. S.Sharifi-RadM.Sharifi-RadM.IritiM.Sharifi-RadM.et al (2015). Phytochemical compositions and biological activities of essential oil from Xanthium strumarium L. Molecules20. 10.3390/molecules20047034
217
ShittuO. B.AjayiO. L.BankoleS. O.PopoolaT. O. S. (2016). Intestinal ameliorative effects of traditional Ogi-tutu, Vernonia amygdalina and Psidium guajava in mice infected with Vibrio cholera. Afr. Health Sci.16, 620–628. 10.4314/ahs.v16i2.33
218
SilvaD. M.CostaP. A. D.RibonA. O. B.PurgatoG. A.GasparD.-M.DiazM. A. N. (2019). Plant extracts display synergism with different classes of antibiotics. An. Acad. Bras. Ciênc.91, e20180117. 10.1590/0001-3765201920180117
219
SilvaF.FerreiraS.QueirozJ. A.DominguesF. C. (2011). Coriander (Coriandrum sativum L.) essential oil: its antibacterial activity and mode of action evaluated by flow cytometry. J. Med. Microbiol.60, 1479–1486. 10.1099/jmm.0.034157-0
220
SivasankariB.AnandharajM.GunasekaranP. (2014). An ethnobotanical study of indigenous knowledge on medicinal plants used by the village peoples of Thoppampatti, Dindigul district, Tamilnadu, India. J. Ethnopharmacol.153, 408–423. 10.1016/j.jep.2014.02.040
221
SnoussiM.DehmaniA.NoumiE.FlaminiG.PapettiA. (2016). Chemical composition and antibiofilm activity of Petroselinum crispum and Ocimum basilicum essential oils against Vibrio spp. strains. Microb. Pathog.90, 13–21. 10.1016/j.micpath.2015.11.004
222
StermitzF. R.LorenzP.TawaraJ. N.ZenewiczL. A.LewisK. (2000). Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5'-methoxyhydnocarpin, a multidrug pump inhibitor. Proc. Natl. Acad. Sci. U. S. A.97, 1433–1437. 10.1073/pnas.030540597
223
StevensP. F. (2001). Angiosperm phylogeny website. Version 14, July 2017.
224
SultanaB.AnwarF.AshrafM. (2009). Effect of extraction solvent/technique on the antioxidant activity of selected medicinal plant extracts. Molecules14, 2167–2180. 10.3390/molecules14062167
225
TanJ. B. L.LimY. Y. (2015). Critical analysis of current methods for assessing the in vitro antioxidant and antibacterial activity of plant extracts. Food Chem.172, 814–822. 10.1016/j.foodchem.2014.09.141
226
TanY. P.ChanE. W. C. (2014). Antioxidant, antityrosinase and antibacterial properties of fresh and processed leaves of Anacardium occidentale and Piper betle. Food Biosci.6, 17–23. 10.1016/j.fbio.2014.03.001
227
TangH.PorrasG.BrownM. M.ChassagneF.LylesJ. T.BacsaJ.et al (2020). Triterpenoid acids isolated from Schinus terebinthifolia fruits reduce Staphylococcus aureus virulence and abate dermonecrosis. Sci. Rep.10, 8046. 10.1038/s41598-020-65080-3
228
TariqS.WaniS.RasoolW.ShafiK.BhatM. A.PrabhakarA.et al (2019). A comprehensive review of the antibacterial, antifungal and antiviral potential of essential oils and their chemical constituents against drug-resistant microbial pathogens. Microb. Pathog.134, 103580. 10.1016/j.micpath.2019.103580
229
TekwuE. M.PiemeA. C.BengV. P. (2012). Investigations of antimicrobial activity of some Cameroonian medicinal plant extracts against bacteria and yeast with gastrointestinal relevance. J. Ethnopharmacol.142, 265–273. 10.1016/j.jep.2012.05.005
230
ThielmannJ.MuranyiP.KazmanP. (2019). Screening essential oils for their antimicrobial activities against the foodborne pathogenic bacteria Escherichia coli and Staphylococcus aureus. Heliyon5, e01860. 10.1016/j.heliyon.2019.e01860
231
TincusiB. M.JiménezI. A.BazzocchiI. L.MoujirL. M.MamaniZ. A.BarrosoJ. P.et al (2002). Antimicrobial terpenoids from the oleoresin of the Peruvian medicinal plant Copaifera paupera. Planta. Med.68, 808–812. 10.1055/s-2002-34399
232
Tsouh FokouP.Kissi-TwumA.Yeboah-ManuD.Appiah-OpongR.AddoP.Tchokouaha YamtheL.et al (2016). In vitro activity of selected west african medicinal plants against Mycobacterium ulcerans disease. Molecules21, 445. 10.3390/molecules21040445
233
TuY. (2016). Artemisinin-A gift from traditional Chinese medicine to the world (nobel lecture). Angew. Chem. Int. Ed.55, 10210–10226. 10.1002/anie.201601967
234
TurcotteM. M.DaviesT. J.ThomsenC. J. M.JohnsonM. T. J. (2014). Macroecological and macroevolutionary patterns of leaf herbivory across vascular plants. Proc. R. Soc. B.281, 20140555. 10.1098/rspb.2014.0555
235
TyagiA. K.MalikA. (2011). Antimicrobial potential and chemical composition of Mentha piperita oil in liquid and vapour phase against food spoiling microorganisms. Food Contr.22, 1707–1714. 10.1016/j.foodcont.2011.04.002
236
UN (2011). “Convention on biological diversity,” in Nagoya protocol on access to genetic resources and the fair and equitable sharing of benefits arising from their utilization. Nagoya, Japan: Nagoya Protocol
237
VaillancourtK.LebelG.YiL.GrenierD. (2018). In vitro antibacterial activity of plant essential oils against Staphylococcus hyicus and Staphylococcus aureus, the causative agents of exudative epidermitis in pigs. Arch. Microbiol.200, 1001–1007. 10.1007/s00203-018-1512-4
238
van VuurenS. F.NkwanyanaM. N.De WetH. (2015). Antimicrobial evaluation of plants used for the treatment of diarrhoea in a rural community in northern maputaland, KwaZulu-natal, South Africa. BMC Compl. Alternative Med.15, 53. 10.1186/s12906-015-0570-2
239
VandebroekI. (2013). Intercultural health and ethnobotany: how to improve healthcare for underserved and minority communities?. J. Ethnopharmacol.148, 746–754. 10.1016/j.jep.2013.05.039
240
VieiraR. G. L.MoraesT. D. S.SilvaL. D. O.BianchiT. C.VenezianiR. C. S.AmbrósioS. R.et al (2018). In vitro studies of the antibacterial activity of Copaifera spp. oleoresins, sodium hypochlorite, and peracetic acid against clinical and environmental isolates recovered from a hemodialysis unit. Antimicrob. Resist. Infect. Contr.7, 14. 10.1186/s13756-018-0307-3
241
ViswanathanV.PharandeR.BannalikarA.GuptaP.GuptaU.MukneA. (2019). Inhalable liposomes of Glycyrrhiza glabra extract for use in tuberculosis: formulation, in vitro characterization, in vivo lung deposition, and in vivo pharmacodynamic studies. Drug Dev. Ind. Pharm.45, 11–20. 10.1080/03639045.2018.1513025
242
VitaliniS.PuricelliC.MikereziI.IritiM. (2015). Plants, people and traditions: ethnobotanical survey in the Lombard Stelvio National Park and neighbouring areas (Central Alps, Italy). J. Ethnopharmacol.173, 435–458. 10.1016/j.jep.2015.05.036
243
VokouD.KatradiK.KokkiniS. (1993). Ethnobotanical survey of Zagori (Epirus, Greece), a renowned centre of folk medicine in the past. J. Ethnopharmacol.39, 187–196. 10.1016/0378-8741(93)90035-4
244
VoukengI. K.BengV. P.KueteV. (2017). Multidrug resistant bacteria are sensitive to Euphorbia prostrata and six others Cameroonian medicinal plants extracts. BMC Res. Notes10, 321. 10.1186/s13104-017-2665-y
245
WangX.ZhangH.ChenL.ShanL.FanG.GaoX. (2013). Liquorice, a unique “guide drug” of traditional Chinese medicine: a review of its role in drug interactions. J. Ethnopharmacol.150, 781–790. 10.1016/j.jep.2013.09.055
246
WatermanP. G. (1993). “Phytochemical diversity in the order Rutales,”in Phytochemical potential of tropical plants. Editors DownumK. R.RomeroJ. T.Stafford.H. A. (New York, NY, USA: Plenum), 203–233.
247
WHO (2019a). Antibacterial agents in clinical development: an analysis of the antibacterial clinical development pipeline. Geneva, Switzerland: World Health Organization.
248
WHO (2019b). Antibacterial agents in preclinical development: an open access database. Geneva, Switzerland: World Health Organization.
249
WHO (2016). International statistical classification of diseases and related health problems 10th revision (ICD-10). Available at: https://icd.who.int/browse10/2016/en.
250
WiegandI.HilpertK.HancockR. E. W. (2008). Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat. Protoc.3, 163–175. 10.1038/nprot.2007.521
251
WijesundaraN.RupasingheH. (2019). Bactericidal and anti-biofilm activity of ethanol extracts derived from selected medicinal plants against Streptococcus pyogenes. Molecules24, 1165. 10.3390/molecules24061165
252
WikströmN.KainulainenK.RazafimandimbisonS. G.SmedmarkJ. E. E.BremerB. (2015). A revised time tree of the asterids: establishing a temporal framework for evolutionary studies of the coffee family (Rubiaceae). PloS One10, e0126690. 10.1371/journal.pone.0126690
253
WilliamsD. A.OverholtW. A.CudaJ. P.HughesC. R. (2005). Chloroplast and microsatellite DNA diversities reveal the introduction history of Brazilian peppertree (Schinus terebinthifolius) in Florida. Mol. Ecol.14, 3643–3656. 10.1111/j.1365-294x.2005.02666.x
254
RBGWillisK. J. (2017). State of the World’s plants, 2017. Kew, London: England: Royal Botanic Gardens.
255
WinkM. (2020). Evolution of the angiosperms and Co-evolution of secondary metabolites, especially of alkaloids. Co-evolution of secondary metabolites. Editors MérillonJ.-M.RamawatK. G. (Cham, Switzerland: Springer International Publishing), 151–174.
256
WinkM. (2003). Evolution of secondary metabolites from an ecological and molecular phylogenetic perspective. Phytochemistry64, 3–19. 10.1016/s0031-9422(03)00300-5
257
WinkM. (2010). Introduction. Annual plant reviews, biochemistry of plant secondary metabolism. (Hoboken, NJ, USA: Blackwell Publishing Ltd). Vol. 40, 1–20. 10.1002/9781444318876.ch1
258
WuC.LeeS.-L.TaylorC.LiJ.ChanY.-M.AgarwalR.et al (2020). Scientific and regulatory approach to botanical drug development: a U.S. FDA perspective. J. Nat. Prod.83, 552–562. 10.1021/acs.jnatprod.9b00949
259
ZaynabM.FatimaM.AbbasS.SharifY.UmairM.ZafarM. H.et al (2018). Role of secondary metabolites in plant defense against pathogens. Microb. Pathog.124, 198–202. 10.1016/j.micpath.2018.08.034
260
ZhaoL.-Y.LiuH.-X.WangL.XuZ.-F.TanH.-B.QiuS.-X. (2019). Rhodomyrtosone B, a membrane-targeting anti-MRSA natural acylgphloroglucinol from Rhodomyrtus tomentosa. J. Ethnopharmacol.228, 50–57. 10.1016/j.jep.2018.09.011
261
ZpetkeviciuteI.SavickieneN.SavickasA.BernatonieneJ.SimaitieneZ.KalvenieneZ.et al (2010). Urban ethnobotany study in Samogitia region, Lithuania. J. Med. Plants Res.4, 64–71.
Summary
Keywords
ethnopharmacology, antibacterial, medicinal plants, antimicrobial, minimum inhibitory concentration
Citation
Chassagne F, Samarakoon T, Porras G, Lyles JT, Dettweiler M, Marquez L, Salam AM, Shabih S, Farrokhi DR and Quave CL (2021) A Systematic Review of Plants With Antibacterial Activities: A Taxonomic and Phylogenetic Perspective. Front. Pharmacol. 11:586548. doi: 10.3389/fphar.2020.586548
Received
23 July 2020
Accepted
12 November 2020
Published
08 January 2021
Volume
11 - 2020
Edited by
Javier Echeverria, University of Santiago, Chile
Reviewed by
Lyndy Joy McGaw, University of Pretoria, South Africa
Alejandro Urzua, University of Santiago, Chile
Updates
Copyright
© 2021 Chassagne, Samarakoon, Porras, Lyles, Dettweiler, Marquez, Salam, Shabih, Farrokhi and Quave.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Cassandra L. Quave, cassandra.leah.quave@emory.edu
These authors have contributed equally to this work and share first authorship
This article was submitted to Ethnopharmacology, a section of the journal Frontiers in Pharmacology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.